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CHAPTER 1: INTRODUCTORY REVIEW 
 
1.1 Plant foods and health 
Plant foods are at the basis of dietary patterns that promote health and decrease risk of chronic 
diseases, as reported by important epidemiological evidences. 
Plant foods, such as fruits, vegetables, legumes and whole grain cereals, tend to be a rich 
source of dietary fibre, vitamins, minerals, phytochemicals, antioxidants and other 
micronutrients, all factors able to contribute to the cardiovascular protective effects, although 
the physiological mechanism involved are far from being elucidated. 
 
 
1.1.1 Whole-grain cereals 
There is growing evidence that whole-grain cereal products protect against the development 
of chronic diseases such as obesity (Koh-Banerjee and Rimm 2003, Van de Vijver et al. 
2009), metabolic syndrome (Sahyoun et al. 2006, Esmaillzadeh et al. 2005), type 2 diabetes 
(de Munter et al. 2007, Murtaugh et al. 2003), cardiovascular diseases (CVD) (Mellen et al. 
2008) and cancers (Chan et al. 2007, Chatenoud et al. 1998, Larsson et al. 2005, Schatzkin et 
al. 2008). 
A meta-analysis of seven prospective cohort studies found a consistent inverse association 
between whole, but not refined, cereal grains and the incidence of cardiovascular disease, 
including heart disease, stroke, fatal CVD (Mellen et al. 2008). Further, the results from the 
Nurses’ Health Study have demonstrated that increased intake of whole grains may protect 
against CHD (Liu et al. 1999) while other prospective data support the reduction of ischemic 
stroke risk (Liu et al. 2000 b).  
A meta-analysis of 12 studies, evaluating the association between dietary fibre and CHD, 
shows that a regular intake of whole grain foods reduces the CHD risk by about 26%. A risk 
ratio of 0.74 (95% CI, 0.67 to 0.80) was found in individuals with the highest intake 
compared to individuals with the lowest intake of whole grains. It was observed that 
vegetable or fruit intake had a modest protective effect and, concluding, the authors suggest 
that three servings of whole grains per day may confer an important cardioprotective effect 
(Anderson et al. 2000). Sahyoun et al. (2006) also encourage elder and young adults to 
increase their daily intake to ≥ 3 servings/d, as the conclusion of their study on whole-grain 
intake and the metabolic syndrome and mortality from cardiovascular disease.  
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In the Iowa Women’s Health Study, that tested the relationship of whole grain fibre 
consumption with risk for all-causes mortality, the participants that consumed whole grain 
reported lower cancer, and CHD mortality, with a 17% lower mortality rate (RR of 0.83, 95% 
CI 0.73-0.94) for women who consumed an amount (fibre/2000 kcal) of 1.9 g from refined 
grain and 4.7 g from whole grain versus women who consumed predominantly refined grain 
fibre (4.5 g) and only 1.3 g whole grain fibre/2000 kcal (Jacobs et al. 2000). Other reviews, 
based on case-control and prospective studies (Jacobs et al. 1995, Jacobs et al. 1998 a) and 
follow-up analyses (Jacobs et al. 1999, Jacobs et al. 1998 b), reported findings on reduced 
cancer risk associated with higher whole grain intake.  
In the Framingham Offspring Study cohort, a cross-sectional study of 2941 subjects, 
McKeown et al. (2002) examined the whole-grain and refined grain intake and metabolic risk 
factors for cardiovascular disease or type 2 diabetes. After adjustment for potential 
confounders, whole-grain intake resulted inversely associated with body mass index, waist-to-
hip ratio, total cholesterol, LDL cholesterol, and fasting insulin concentration (McKeown et 
al. 2002).  
 
 
1.1.2 Fruits and vegetables 
As reported by many epidemiological studies the consumption of fruits and vegetables is 
associated with a decrease in the incidence of cardiovascular disease (CVD), including stroke 
and CHD (Liu et al. 2000 a, Liu et al. 2001, Bazzano et al. 2002, Gillman et al. 1995, 
Joshipura et al. 2001, Sasazuki 2001, Zhao and Chen 2001).  
The Nurses' Health Study and the Health Professionals' Follow-Up Study, both prospective 
cohort studies, included a total of 126399 healthy volunteers at recruitment, for a total of 84 
251 women and 42 148 men for 14 and 8 years of follow up. The results, after adjustment for 
common cardiovascular risk factors, demonstrated that the subjects in the highest quintile of 
fruit and vegetable intake had a relative risk (RR) for coronary heart disease of 0.80 (95% 
confidence interval CI, 0.69 to 0.93) compared with those in the lowest quintile of intake. A 
dose-response analysis indicates that each increase of 1-serving/d in intake of fruits or 
vegetables lowered the risk for coronary heart disease of 4%. The most important contributor 
to the protective effect of total fruit and vegetable intake were green leafy vegetables, with a 
RR 0.77 (CI, 0.64 to 0.93), and vitamin C–rich fruits and vegetables, with a RR 0.94 (CI, 0.88 
to 0.99) for each additional serving/d. An important finding consisted in the protective effect 
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on coronary heart disease demonstrated by green leafy vegetables and vitamin C–rich fruits 
and vegetables (Joshipura et al. 2001). Similar results were obtained by Liu et al. (2001) and 
Liu et al. (2000 a) while examining the relationship between fruit and vegetable intake and 
reduction of CVD risk in a large prospective cohort of women (Women’s Health Study) and 
in male (Physicians’ Health Study) .  
In the Framingham Study, a cohort study involving middle-aged men with more than 20 years 
of follow-up, fruits and vegetables were found marginally protective against the development 
of stroke. An increase of 3 servings/d of fruit and vegetables was associated with a RR of 0.75 
(95% CI: 0.55, 1.03) for ischemic stroke (Gillman et al. 1995).  
In the first National Health and Nutrition Examination Survey Epidemiologic Follow-up 
Study, the increased consumption of fruit and vegetables was inversely associated with stroke 
incidence, stroke mortality, ischemic heart disease mortality, and CVD mortality. The 
reduction (27%) of the incidence of stroke was achieved in the case of 3 servings/d compared 
with less that 1 time/d (RR 0.73; 95% CI, 0.57 to 0.95) (Bazzano et al. 2002). 
Even if many comparable results concerning the protective effects of fruits and vegetables for 
risk of stroke have been reported (Bazzano et al. 2002, Gillman et al. 1995, Zhao and Chen 
2001), some researchers did not find a protective effect on CHD with increased intake of fruit 
and vegetable (probably because of difficulties in collecting the data) (Rosengren et al. 1999, 
Sasazuki 2001).  
The effects of higher intake of fruits and vegetables were also widely examined with respect 
to the reduction in risk of different forms of cancers. In the Nurses’ Health Study and the 
Health Professionals’ Study, the association between lung cancer risk and fruit and vegetable 
consumption was examined in 77283 women and 47778 men. For women the risk was lower 
for total fruit and vegetable consumption, with a RR for the highest versus lowest quintile of 
intake of  0.79 (95% CI, 0.59 to 1.06). For men results were not the same. However, for both 
sexes, after taking into account smoking status, the total fruit and vegetable consumption 
showed an inverse association with the risk of lung cancer, though not statistically significant 
(RR  0.63; 95% CI, 0.35 to 1.12 in the highest tertile of intake) (Feskanich et al. 2000). 
The correlation between fruit and vegetable consumption and the incidence of colon and 
rectal cancers was also prospectively investigated in the Nurses’ Health Study (88764 
women) and the Health Professionals’ Follow-up Study (47325 men) but resulted in no 
association. The authors noted that a significant reduction in colorectal cancer risk is more 
often found in case–control studies than in the more epidemiologically powerful prospective 
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cohort studies; nevertheless, they advocate a diet rich in fruit and vegetable because of 
protection against other diseases ( Michels et al. 2000).  
The relationship between breast cancer and fruit and vegetable consumption was examined by 
Gandini and colleagues (2000) in a meta-analysis of 26 published studies. The relative risk, 
based upon a random effects model, for ‘high consumption’ compared with ‘low 
consumption’ was 0.75 (95% CI, 0.66 to 0.85) in 17 studies on vegetable and 0.94 (95% CI, 
0.79 to 1.11) in 12 studies on fruit consumption (Gandini et al. 2000). While these authors 
confirm the association between intake of vegetables and, to a lesser extent, fruits with breast 
cancer, Smith-Warner et al. (2001) found a non significant association in another meta-
analytical study with data pooled from eight prospective studies. 
In a multiethnic case-control study of African-American, white, Japanese, and Chinese men, 
Kolonel et al. (2000) examined the relationship between vegetables, fruits, and legumes and 
prostate cancer. After adjustment for common risk factors, they obtained an inverse 
association, mainly for advanced cases, with the intake of yellow-orange and cruciferous 
vegetables. The OR of the highest quintile for yellow-orange vegetables was of 0.67 (P for 
trend 0.01) and that of the highest quintile for cruciferous vegetables was of 0.61 (P for trend 
0.006). An inverse correlation was also found with legume intake (OR of 0,62; P for trend 
0,0002 for highest relative to lowest quintile of total legumes) while fruits were not related to 
cancer risk (Kolonel et al. 2000).  
 
 
1.1.3 Legumes  
Considering the data in literature, it can be noted that the correlation between legumes and 
CHD has been seldom assessed, if compared to cereals; moreover, the few existing studies are 
focused mainly on specific nutritional components of legumes and not on total dietary intake. 
The First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study 
(NHEFS), that involved 9632 participants, indicates a significant inverse relationship between 
total legume intake and the risk of CHD and CVD, with a reduction of 22% (RR 0.78; 95% 
CI, 0.68-0.90) and 11% (RR, 0.89; 95% CI, 0.80-0.98) respectively (Bazzano et al. 2001). 
Flight and Clifton (2006), in reviewing the literature, reported that - along with cereal grains - 
legumes are preventive against coronary heart disease and stroke.  
Venn and Mann (2004) have examined the evidence for the role of whole grain foods and 
legumes in the management of diabetes, suggesting a strong evidence for a beneficial effect.  
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1.2 Mechanisms of action 
Based on the existent epidemiological studies, there is strong evidence that plant foods play a 
role in CVD prevention, since they provide dietary fibre that helps lower blood cholesterol, 
antioxidants that help reduce lipoprotein oxidation, and methyl donors that help control 
plasma homocysteine, all strong risk factors for the development of CVD (Getz and Reardon 
2007, Fardet 2010). However, the mechanisms of action are possibly broader than currently 
thought and need further in-depth examination, also considering that foods are biochemically 
complex as well as their ample content of nutrients, which may interact with one another.  
 
In cereals it is agreed that the biological effect is result of the synergistic action of a large 
number of compounds, mainly contained in the bran and germ fractions (Jensen et al. 2006, 
Liu 2007). In wheat, functional compounds include fibre, polyphenols (especially phenolic 
acids such as ferulic acid and smaller amounts of flavonoids and lignans), n-3 fatty acids, 
sulphur amino acids, oligosaccharides (stachyose, raffinose and fructans), lignin, minerals, 
trace elements, vitamins B and E, carotenoids, alkylresorcinols, phytic acid, betaine, total 
choline-containing compounds, inositols, phytosterols, policosanol, melatonin. Each one of 
these compounds has physiological functions and, possibly, health benefits, among which 
reduction of oxidative stress, inflammation, hyperglycaemia, all leading to prevention of CVD 
(Fardet et al. 2008, Fardet 2010, Seal 2006).  
In a recent publication, Fardet (2010) discusses new hypotheses for the health-protective 
mechanisms of whole-grain cereals. The author claims that antioxidant protection should not 
be reduced to free radical scavenging and antioxidant enzyme activation, but also the 
involvement of polyphenols in cell signalling and gene regulation, and of sulphur compounds, 
lignin and phytic acid in other different aspects of cell metabolism must be taken into account. 
Furthermore, whole-wheat is a rich source of methyl donors, such as betaine and choline, 
which may be involved in cardiovascular and/or hepatic protection, lipid metabolism and 
DNA methylation. Betaine, which is present up to 1% (w/w) in the wheat bran fraction 
(Zeisel et al. 2003) is probably primarily involved in lowering homocysteine; this might of 
interest considering that high consumption of whole grains, bran and germ, was associated 
with a significant decrease in plasma homocysteine in a cross-sectional study on healthy men 
and women (Jensen et al. 2006). 
The beneficial effect of fruit and vegetable could be ascribed to several individual nutrients 
such as fibre, potassium, and folate, but especially it has been suggested that the reduced 
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CVD risk result from the high polyphenol content of these foods (Bazzano et al. 2002, Tribble 
1999).  
The oxidant stress, generated by excessive production of reactive oxygen species, is involved 
in the pathogenesis of many cardiovascular conditions, including hypercholesterolemia, 
atherosclerosis, hypertension and heart failure (Cai and Harrison 2000), and antioxidants such 
as dietary polyphenols might play an important role in the prevention of CVD (Tribble 1999, 
Chong et al. 2010). Polyphenols present in fruits and vegetables, chocolate, red wine, green 
tea and other plant foods have important free radical-scavenging properties in vitro. Although 
the protective effect of polyphenol-rich plant foods was initially ascribed to their antioxidant 
properties, involved in protection against lipid peroxidation, in the last years the mechanism 
of action of plant compounds has been discovered to be more complex than originally 
expected (Manach et al. 2005, Williams et al. 2004). For example, considering that 
polyphenols may exert modulatory action in cell metabolism, a reduction of oxidative stress 
could be related to a decreasing in the production of superoxide anion through the regulation 
of NADPH oxidase, the key enzyme of oxidative stress (Williams et al. 2004).  
The protective action of legumes could be correlated, beside the high content in folates 
important for the metabolism of homocysteine, with their high content in vegetable protein 
and also in soluble fiber, which reduce total and low-density lipoprotein cholesterol levels as 
well as insulin resistance (Bazzano et al. 2001). By replacing protein from vegetable sources 
(soybean) for protein from animal sources the concentration of serum cholesterol can be 
reduced, as demonstrated in randomized clinical trials (Anderson et al. 1995). The low 
content in sodium and high content in minerals such as potassium, calcium, and magnesium, 
associated with a reduced risk of cardiovascular disease in epidemiologic studies (He et al. 
1999, Sasaki et al. 1995, Ascherio et al. 1998) could be another explanation for such a 
beneficial effect (Bazzano et al. 2001).  
 
 
 
 
 
 
 
 
11 
1.3 Cardiovascular diseases 
Atherosclerosis is a chronic inflammatory disease, associated with risk factors such as 
hyperlipidemia, diabetes, and hypertension. Endothelial dysfunction has been proposed to be 
the first step in atherosclerosis, with other possible causes including elevated and modified 
Low-density lipoprotein (LDL), free radicals, genetic alterations, elevated plasma 
homocysteine concentrations, and infectious microorganisms (Ross 1999). 
As result of injury, the normal homeostatic properties of the endothelium are altered and some 
of the following modifications can occur: increased adhesiveness of leukocytes or platelets to 
the endothelium, increased permeability, increased pro-coagulant properties and formation of 
vasoactive molecules, cytokines, and growth factors. Subsequently, if this state persists, the 
inflammatory response stimulates migration and proliferation of smooth-muscle cells into the 
intima media, with resulting intermediate lesion later followed by thickening of the artery 
wall. The increased numbers of macrophages and lymphocytes resulting from continued 
inflammation, and their activation, entails the release of hydrolytic enzymes, cytokines, 
chemokines, and growth factors, which can induce further damage and eventually lead to 
focal necrosis (Ross 1999).  
 
 
1.3.1 Inflammation, oxidative stress and CVD 
Different data provide strong evidence that inflammation and oxidative stress are implicated 
in the pathogenesis of atherosclerosis (Libby 2007, Stocker and Keaney 2005).  
C-reactive protein (CRP) is a marker of subclinical inflammation and represents a strong 
independent risk factor for cardiovascular disease (Ridker 2003). It is synthesized primarily 
by hepatocytes in response to different cytokines, such as interleukin (IL)-6, IL-1, tumour 
necrosis factor (TNF), and other (Fredrikson et al. 2004). 
CRP induces oxidative stress by increasing production of superoxide from NAD(P)H oxidase 
via p38 kinase activation, for example in the endothelium (Qamirani et al. 2005). CRP can 
also induce the formation of ROS in vascular smooth muscle cells by affecting their pro-
inflammatory activities (Ryu et al. 2007).  
Hattori et al. (2003) have shown that the responses to CRP in vascular smooth muscle cells 
were much more complex. CRP induces parallel activation of the redox-responsive 
transcription factors NF-kappa B (NF-kB) and AP-1 and increases the activity of the MAP 
kinases (MAPKs), extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase 
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(JNK) and p38MAPK. Moreover, CRP increases the expression of monocyte chemoattractant 
peptide (MCP-1) and interleukin-6 (IL-6).  
CRP is an active participant in atherosclerosis; it is present in atherosclerotic plaques, binds to 
low-density lipoprotein (LDL) promoting its uptake by macrophages, and also contributes to 
release the matrix metalloproteinase (implicated in plaque rupture) (Torzewski et al. 2000, 
Zwaka et al. 2001, Singh et al. 2008). 
CRP levels are associated with diet, lifestyle and metabolic cardiovascular risk factors and 
many studies have found correlations with age, body mass index, smoking, insulin sensitivity, 
plasma triglycerides, fasting glucose, and low HDL colesterol (Ridker et al. 2003, Freeman et 
al. 2002, Yudkin et al. 1999, Festa et al. 2000, Pradhan et al. 2001).  
 
 
1.3.2 Nutrition and CVD 
Among noncommunicable diseases, the major contributor to the global burden of disease is 
represented by CVD leading to 30% of global deaths as estimated by the World Health 
Organization (WHO 2007). Reporting the recommendations in preventing chronic diseases, 
WHO summarizes the evidences that affect the risk factors for CVD (WHO 2003).  
In a recent review, Mente et al. (2009) have investigated dietary exposures in relation to 
CHD. The results from prospective cohort studies or randomized trials have shown that 
protective factors such as vegetables, nuts, and “Mediterranean” and high-quality dietary 
patterns were well associated with CHD risk reduction, as supported by strong evidence; 
conversely, intake of trans–fatty acids and foods with a high glycemic load were identified as 
harmful factors. Additionally, strong evidences were reported for monounsaturated fatty acids 
and “prudent” and “western” dietary patterns.  
Intake of folate, whole grains, fish, marine ω-3 fatty acids, dietary vitamins E and C, beta 
carotene, alcohol, fruit, and fibre have moderate evidence of protective associations while the 
intake of supplementary vitamin E and ascorbic acid (vitamin C), saturated and 
polyunsaturated fatty acids, total fat, α-linolenic acid, meat, eggs and milk present insufficient 
evidence (Mente et al. 2009).  
 
1.3.3 Antioxidants and CVD 
According to the oxidative hypothesis of atherosclerosis (Berliner and Heinecke 1996), the 
oxidized low-density lipoproteins (LDL) play a central role in atherogenesis (Young and 
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McEneny 2001). The LDL undergo oxidative modification in the subendothelial space 
mediated by reactive oxygen species (ROS) and reactive nitrogen species (RNS) (Patel et al. 
2000). These modifications implicate many cell types, such as monocytes, macrophages, 
neutrophils, endothelial cells, smooth muscle cells and fibroblasts, including NADPH oxidase 
as one of the potential oxidative mechanisms (Young and McEneny 2001). NADPH oxidase 
is a membrane-associated enzyme able to catalyse the one-electron reduction of oxygen 
(Babior 1999). 
The degenerative process includes different steps. First, when oxidation is minimal, the LDL 
are minimally oxidised and are characterized by intact ApoB-100, loss of polyunsaturated 
fatty acids and antioxidants with respect to native lipoprotein. The oxidation of phospholipids 
occurs on the surface of LDL particles (Parthasarathy et al. 1999). The minimally modified 
oxidised low-density lipoprotein (MM-LDL) can induce the expression of monocyte 
chemotactic protein-1 (MCP-1) and macrophage colony-stimulating factor (M-CSF) by 
endothelial cells, leading to monocyte recruitment from the arterial wall and differentiation of 
monocytes into macrophages. Such forms of LDL are recognized by LDL receptors but not 
by scavenger receptors of macrophages. The advanced oxidised form of LDL are 
characterised by modified apoB and can activate endothelial cells with expression of adhesion 
molecules that, together with MCP-1, promote adhesion and entry of monocytes into arterial 
wall. Once differentiated into macrophages, monocytes internalize the oxidised LDL particles 
through scavenger receptors because of higher affinity, accumulating an important amount of 
intracellular lipids in the arterial wall. The result is the release of proinflammatory cytokines 
by macrophages, which further promote recruitment of monocytes and accumulation of foam 
cells, thus inducing a vicious circle (Lapointe et al. 2006).  
The LDL oxidation process could be influenced by consumption of foods and nutrients with 
antioxidant properties (Lapointe et al. 2006). It is interesting to note that, in animal models, 
fruit and vegetable antioxidant extract has been shown to prevent both NAD(P)H oxidase 
expression and O2°- overproduction. It was also shown a decrease of cholesterol 
concentration, significant increase of plasma antioxidant capacity, and prevention of fatty 
streak formation in aortic arch in the heart from hypercholesterolemic hamster (Sutra et al. 
2007). The oxidative stress and p22phox NADPH oxidase activation can be reduced by a 
moderate consumption of red wine, which also affect the progression of aortic lesions in an 
experimental model of diet-induced atherosclerosis (Qian et al. 2009). 
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Generally, the combination of antioxidant compounds that characterise the healthy food 
pattern of the Mediterranean diet appears effective to decrease the oxidation of LDL particle 
leading to cardiovascular protection (Lapointe et al.2006).  
 
 
1.3.4 Betaine, choline and CVD  
The relationship between betaine and choline and CVD could be explained through their 
effect on homocysteine, which can itself be an independent risk factor for cardiovascular 
disease (Craig  2004, Zeisel and Blusztajn 1994). 
Betaine, a vital methylating agent (Craig 2004) and its precursor choline are important in 
maintaining the normal one-carbon metabolism and homocysteine homeostasis (James et al. 
2002).  
In humans with cardiovascular disease, there is a significant inverse relationship between 
plasma betaine and homocysteine concentrations in fasting (Schwahn et al. 2003 a) and 
postmethionine states (Holm et al. 2004). For example, the supplementation in healthy 
volunteers with 1.5–6 g/day betaine or 2.6 g/day choline (as phosphatidylcholine) can 
significantly lower fasting homocysteine (Olthof et al. 2003, Schwab et al. 2002, Steenge et 
al. 2003).  
Chiuve et al. (2007) found an inverse association between total choline and betaine intake and 
total homocysteine in women, concluding that remethylation of total homocysteine may be 
more dependent on the betaine pathway when methyl sources are low as a result of either 
inadequate folate intake or heavier alcohol consumption. 
In the ATTICA study, Detopoulou et al. (2008) found that, in free-eating and healthy adults, a 
major dietary intake of choline and betaine was independently associated with a reduction in 
inflammation indexes (C-reactive protein, interleukin-6, tumor necrosis factor-α, 
homocysteine) important players in cardiovascular disease progression.  
Data suggest that non-alcoholic fatty liver disease (NAFLD), a common condition in people 
with type 2 diabetes, is associated with a high prevalence of cardiovascular disease risk 
(Targher et al. 2007, Targher et al. 2005). It has been shown that molecules that reduce the 
accumulation of fat in the liver, such as betaine and choline, are able to reduce the incidence 
of NAFLD (Patrick 2002, Angulo 2003). In an animal model betaine improved nonalcoholic 
fatty liver by reversing hepatic insulin resistance (Kathirvel et al. 2010). 
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1.4 Homocysteine  
 
Homocysteine is an amino acid derived from methionine, an essential amino acid, that contain 
an readly oxidable thiol group (Jacobsen 2000). The concentrations in blood increase with age 
and sex and are affected by renal function (Gori et al. 2005, Powers et al. 2002, Selhub 1999, 
Mayer et al. 1996). In people with hyperhomocysteinemia, very high blood levels of 
homocysteine are independently associated with higher risk for atherosclerosis (Clarke et al. 
1991).  
 
At physiological pH in the presence of O2, the reactive sulfhydryl group (-SH) of 
homocysteine can undergo oxidation to different molecular disulfides (RSSR) (Jacobsen 
2000). When methionine is in excess, the homocysteine can be irreversibly degraded to 
cysteine, via vitamin B6-dependent reactions (transulfuration pathway). This process 
generates cystathionine as intermediate product, catalyzed by cystathionine–βsynthase (CBS). 
Homocysteine is involved in two pathways to conserve methionine when the balance is 
negative (Figure 1). The remethylation into methionine requires vitamin B12 and, in most 
tissues, this process is catalyzed by the ubiquitous methionine synthase (MS) that uses 
methyltetrahydrofolate as the substrate. Methyltetrahydrofolate formation, in turn, is 
catalyzed by the enzyme methylenetetrahydrofolate reductase (MTHFR). In the liver betaine 
is a methyl donor for the enzyme betaine-homocysteine methyltransferase (BHMT) (Refsum 
and Ueland 1998). 
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Figure 1. Homocysteine metabolism 
 
1.4.1 Homocysteinemia 
Elevated serum homocysteine concentration (hyperhomocyst(e)inemia or 
homocyst(e)inemia), as reported by epidemiologic studies, is associated with an increased risk 
of cardiovascular disease, stroke, Alzheimer disease, dementia, neural tube defects, and other 
metabolic disorders (Selhub 1999, Seshadri et al. 2002, Kittner et al 1999, McCully 1969, 
Wilcken and Wilcken1976). 
Supplementation with folic acid lowers plasma homocysteine (van Oort et al. 2003) and 
betaine can improve the elevated fasting serum homocysteine and an elevated response of 
homocysteine after methionine loading (postmethionine), considered as two independent risk 
factors for cardiovascular disease (Steenge et al. 2003). However it must be noted that a 
recent meta-analysis of 8 intervention trials with homocysteine-lovering agents involving a 
total of 37485 individuals, found no effect on CVD events or cancer over a mean period of 5 
years of follow-up (Clarke et al. 2010). 
The normal mean homocysteine levels are 5 to 15 µM; when the homocysteine levels are 
higher they indicate mild, moderate, and severe hyperhomocysteinemia (16 to 30, 31 to 100, 
and higher than 100 µM) (Welch and Loscalzo 1998). 
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Homocysteinemia is the result of an imbalance in the methionine cycle because of genetic or 
nongenetic (nutritional) factors, for example deficiency of 5,10-methylenetetrahydrofolate 
reductase MTHFR or deficiency in B Vitamins or folates (Selhub 1999). 
Severe homocysteinemia (homocystinuria) can be caused by a deficiency of CBS 
(cystathionine β- synthase), MTHFR (methylenetetrahydrofolate reductase), or 
methylcobalamin synthesis (Craig 2004).  
Chronic elevation of homocysteine results in parallel increases in intracellular SAH, and the 
ratio SAM(S-adenosylmethionine):SAH(S-adenosylhomocysteine) can influence the cellular 
methylation status important for pathogenesis of diseases related to homocysteinemia (James 
et al. 2002).  
 
 
1.4.2 Hyperhomocysteinemia and oxidative stress  
Homocysteine, as well as other thiols, has pro-oxidant activity and its oxidation to 
homocystine can generate a variety of reactive oxygen species, including superoxide anion 
radical and hydrogen peroxide. Such reaction is catalyzed by transition metals (Jacobsen 
2000). 
 
 HOMOCYSTEINE (RSH) + O2 → HOMOCYSTINE (RSSR) + [O2°-] → H2O2 
 
 
There is also evidence that homocysteine affect nitric oxide (NO) production, which is lower 
when the exposure of endothelial cells to homocysteine increases (Stamler et al. 1993). In 
normal conditions, nitric oxide serves as an endothelium-dependent vasodilator and an 
antithrombotic agent in the vasculature (Upchurch et al. 1996). Homocysteine causes 
dysfunction of the vascular endothelium (Jacobsen 1998), reduces NO generation, impairs 
endothelium-dependent vasodilation (Tawakol et al. 1997) and also causes oxidation of low-
density lipoprotein (LDL) (Heinecke et al. 1987). Also, the superoxide anion generated by 
oxidation of homocysteine is involved in the oxidative modifications of lipids (Olszewski and 
McCully 1993).  
Further, homocysteine is able to attenuate GSHPx (glutathione peroxidase) (Lubos et al. 
2007) and activate NADPH oxidase in human neutrophils and monocytes by phosphorylation 
and subsequently membrane translocation of p47phox and p67phox subunits, leading to 
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enhancement in superoxide anion production (Alvarez-Maqueda et al. 2004, Siow et al. 
2006). 
 
 
1.4.3 Hyperhomocysteinemia and CVD 
Different studies had shown the link between hyperhomocysteinemia and vascular disease. In 
1969, McCully made the first clinical observation about the implication of 
hyperhomocysteinemia in the pathogenesis of atherosclerosis (Mc Cully 1969).  
Mild homocysteinemia, a risk factor for premature arteriosclerotic disease, is characterized by 
mildly elevated fasting or postmethionine homocysteine concentrations, and occurs in 9–42% 
of subjects under 50 y of age who have peripheral or cerebral occlusive arterial disease, 
myocardial infarction, or thromboembolism (Franken et al. 1994). Mild homocysteinemia 
after a standard methionine load is present in young patients with coronary artery disease 
(21%), patients with cerebrovascular disease (24%), and patients with peripheral vascular 
disease (32%) (van den Berg and Boers 1996).  
Different mechanisms for atherosclerosis induced by homocysteine have been suggested:  
endothelial dysfunction, activation of monocytes (resulting in secretion of cytokines), 
increased proliferation of smooth muscle cells, promotion of lipoprotein oxidation and platelet 
activation, and enhanced thrombus formation (Woo et al.1997, Su et al. 2005, Mayer et al. 
1996, Clarke et al. 1991).  
 
 
1.5 Oxidative stress  
The oxidative stress concerns the imbalance between production and elimination of reactive 
oxygen species (ROS) and represents an important factor for a wide variety of cardiovascular 
diseases,  such as atherosclerosis and endothelial dysfunction (Cai and Harrison 2000).   
Reactive oxygen species (ROS) are a large group of molecules, which include the molecular 
oxygen and its derivatives generated in all aerobic cells, and many of them are free radicals 
because of unpaired electrons (Cai and Harrison 2000). ROS produced naturally as 
consequence of aerobic metabolism are important for maintaining tissue oxygen homeostasis 
(Castro and Freeman 2001). 
These molecules play a double role in disease promotion and prevention. At high 
concentrations ROS are detrimental to health because are implicated in the oxidation of 
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biological macromolecules, such as lipids, DNA, protein, carbohydrates. On the other end, at 
moderate concentrations, these signalling molecules have crucial roles in normal 
physiological processes such as in the response to growth factors, apoptotic elimination of 
damaged cells and also in the prevention of disease by helping the immune system (Castro 
and Freeman 2001, Seifried et al. 2007). 
The regulation of ROS activity has been identified as an important factor for the development 
of some diseases, including cancer and cardiovascular disease (CVD) (Kunsch and Medford 
1999, Seifried et al. 2007, Lum and Roebuck 2001). One of the mechanisms of defence is the 
enzymatic antioxidant system that includes catalase, glutathione peroxidase and superoxide 
dismutase. Beside these enzymes, the nonenzymatic activity of exogenous and endogenous 
antioxidants, including polyphenols, glutathione, thiols, some vitamins and metals, may 
represent an alternative for cell protection (Seifried et al. 2007). 
 
 
Figure 2. Cellular oxidative interactions 
 
 
1.5.1 ROS and signal transduction 
The ubiquitous ROS are regulators of signalling cascades at different stages. Downstream 
cellular activities can be modulated by ROS directly or through activation of phospholipases 
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able to generate cofactors and cellular 0messengers that affect the activity of enzymes such as 
protein kinases and phosphatases (Lum and Roebuck 2001). They are capable of tyrosine and 
serine/threonine protein phosphatases inactivation, with a subsequent major activation of 
protein kinases (MAPK, PKC) (Whisler et al. 1995).  
Being essential for the activity of signal transduction pathways, the controlled production of 
ROS can influence the function of the mitogen-activated protein kinases (MAPKs). The MAP 
kinase family, which plays a role in transferring signals from extracellular stimuli to the cell 
nucleus, consists of the extracellular signal–regulated kinases (ERK) subgroup that regulate 
cell proliferation, the c-Jun amino-terminal kinase (JNK), and the p38 MAP kinase, linked to 
stress responses (Seifried et al. 2007, Holbrook and Ikeyama 2002). JNK and p38MAPK, 
activated by environmental stresses and pro-inflammatory cytokines (tumour necrosis factor 
(TNF), interleukin-1 (IL-1), IL-2 and IL-17), can lead to apoptosis and promotion of 
inflammation (Chen at al. 2001, Chang and Karin 2001, Thomas and Huganir 2004).  
As final targets of signal transduction pathways, PKC and MAP kinase pathways can activate 
two major redox-sensitive transcription factors AP-1, with important roles in normal 
development, and NF-kB, involved in the regulation of different physiological functions 
(Lum and Roebuck 2001).  
 
 
1.5.2 NADPH oxidase 
The superoxide anion (O2°-), generated by neutrophils, eosinophils, and mononuclear 
phagocytes and B lymphocytes, is formed by the one-electron reduction of oxygen and 
implies the activity of NADPH as the electron donor.  
 2 O2 + NADPH → 2 O2 ─  + NADP+ + H+  
Subsequently, this anion triggers the generation of other different reactive oxidants, including 
oxidized halogens, free radicals, and singlet oxygen which have beneficial bactericidal 
implication but which need regulation to avoid the toxic effect (Chanock et al. 1994).  
NADPH oxidases are situated in different cells of mesodermal origin. The most studied 
leukocyte NADPH oxidase represents a group of plasma membrane–associated enzymes 
which include: p40PHOX (PHOX for Phagocyte OXidase), p47PHOX, p67PHOX, cytosolic 
complex; p22PHOX , gp91PHOX and membrane bound components (which comprise cytochrome 
b558, a flavohemoprotein; Rap1A and Rac 2 low-molecular-weight guanine nucleotide- 
binding proteins that participate also in other processes).  
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In the resting cell, the NADPH oxidase is inactive and the subunits are distributed between 
the cytosol and the membrane. Once activated by appropriate stimuli, it occurs the 
phosphorylation of the subunit chiefly responsible for transporting p47PHOX , and the entire 
cytosolic complex migrates to the membrane where it associates with cytochrome b558. This 
assemblage allows the transfer of electrons from the NADPH to FAD and then to oxygen, 
probably by involving the heme of cytochrome b558 as a second intermediate electron carrier. 
Activation requires also the involvement of two low-molecular-weight guanine nucleotide- 
binding proteins: Rac2 - located in the resting cell in the cytoplasm in a dimeric complex with 
Rho-GDI (Guanine nucleotide Dissociation Inhibitor) -  and Rap1A - located in membranes. 
During oxidase activation, Rac2 binds guanosine triphosphate (GTP) and migrates to the 
membrane with the other cytosolic factors of the NADPH oxidase (Babior 1999).  
 
 
 
 
Figure 3. Activation of the leukocyte NADPH oxidase  
 
The phosphorylation, an essential step in the activation of the NADPH oxidase, first occurs in 
the cytosol, where the most of the phosphates are present, followed soon by the transfer of 
p47PHOX to the plasma membrane. Besides the phosphorylation of p47PHOX oxidase during 
activation, it has been shown that a phosphorylation of other two subunits p67PHOX (Heyworth 
et al. 1991) and p40PHOX (Chanok et al. 1994) also occurs. 
In the phosphorylated subunit p47PHOX, the phosphate groups were found linked to the 11 
serines (El Benna et al. 1994); this induces a protein conformational change that renders the 
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SH3 domains accessible to the target p22PHOX (Ago et al. 1999). The SH3-mediated 
interaction between p47PHOX and p22PHOX is strictly regulated and plays a key role in 
phagocyte oxidase activation.  
The phosphorylation of p47PHOX  can be regulated by protein kinase. It was shown that PKC 
isoforms expressed in human neutrophils (Fontayne et al. 2002), as well as P21-activated 
kinase (Pak), Akt kinase, and mitogen-activated protein (MAP) kinases, are all implicated in 
the phosphorylation of p47PHOX (Martyn et al. 2005). 
 
1.5.2.1 The NADPH oxidase modulation 
The production of superoxide anion (O2°-) by NADPH oxidase can be modulated through     
transcriptional and post-transductional mechanisms.  
The first regulation is either negative or positive when the expression of the core components 
of NADPH oxidase can be inhibited or not. 3-Hydroxy-3-methylglutaryl coenzyme A 
reductase inhibitors (statins) can suppress the expression of NADPH oxidase subunits 
(Wassmann et al. 2002). Antioxidants supplied by fruits and vegetables can reduce the cardiac 
production of superoxide anion and also p22PHOX subunit of NAD(P)H oxidase expression 
in an animal model (Sutra et al. 2007). Homocysteine are able to modulate positively NADPH 
(Ungvari et al. 2003), and also LPS (DeLeo et al. 1998), and CRP (Kobayashi et al. 2006). 
The post-transductional regulation concerns the phosphorylation of the subunits of NADPH 
and the translocation of the cytosolic oxidase components. The phagocytic elements can 
modulate positively the NADPH oxidase activation (De Leoet al. 1998) with superoxide 
anion production.  
For a negative modulation of oxidase, vitamin E was shown to be able to inhibit the 
phosphorylation of the subunit p47PHOX in monocytes (Cachia et al. 1998) and subsequently 
decrease the superoxide anion production. Pignatelli et al. (2006) have demonstrated that the 
synergistic effect of quercetin and catechin can also lead to inhibition of PKC-dependent 
phosphorylation of the cytosolic sub – unit p47 phox of NADPH oxidase.  
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1.6 Betaine  
Betaine, also known as trimethylglycine, glycine betaine, lycine, and oxyneurine, is a 
zwitterionic quaternary ammonium compound (Figure 4). It is a methyl derivative of the 
amino acid glycine with a molecular weight of 117.2 and 3 chemically reactive methyl groups 
(Craig 2004).  
 
 
 
 
 
 
 
First discovered in the juice of sugar beets (Beta vulgaris) in the 19th century, betaine can be 
found in microorganisms, plants, and animal tissues. Rich food sources are wheat, shellfish, 
spinach, and sugar beets (Koc et al. 2002, Zeisel et al. 2003). 
Betaine plays important physiological roles; being an organic osmolyte it protects cells under 
stress and it acts, via transmethylation, as a source of methyl groups for use in many 
biochemical pathways (Figure 5) (Betaine Monograph).  
Betaine is ingested in unknown amounts through intake of foods which contain the preformed 
molecule or its precursor choline(Zeisel et al. 2003). The choline introduced with the diet can 
have different fates: in part it can be irreversibly oxidized to betaine, whereas the remainder is 
transformed in acetylcholine and phospholipids (phosphatidylcholine) (Zeisel et al. 1991).  
 
 
 
 
 
 
 
 
 
 
Figure 4. Structural formula of betaine 
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Figure 5. Methionine cycle  
B6, vitamin B-6; B12, vitamin B-12 (cobalamin); BHMT, betaine homocysteine methyltransferase; CBS, 
cystathionine β- synthase; MS, methionine synthase; MTHFR, methylenetetrahydrofolate reductase; THF, 
tetrahydrofolate; CH3- THF, 5-methyltetrahydrofolate.  
 
 
 
 
1.6.1 Betaine metabolism 
Being an N-methylated amino acid, the cellular uptake and intracellular accumulation of 
betaine can be mediated by amino acid transport systems, in particular by betaine-gamma 
aminobutyric acid transporter and amino acid transport system A (Peters-Regehr et al. 1999, 
Wettstein et al. 1998, Weik et al. 1998). As shown in animal studies, dietary betaine has an 
increased absorption in the duodenum (Kettunen et al. 2001).  
In human studies the absorption and distribution of betaine after intake is also rapid. Some 
data reveal a peak increase in serum betaine at 1–2 h (Schwahn et al. 2003b). 
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In normal human plasma concentrations of glycine betaine are usually between 20 and 70 
µmol/l (higher in adult males than in females), and in renal disease and diabetes the 
concentrations are lowered and normal, respectively (Schwahn et al. 2003 b, Lever et al. 
1994). 
Betaine is mainly eliminated by metabolism and not excreted (Schwahn et al. 2003 b), except 
in subjects with renal disease or diabetes that present a high urinary excretion (Lever et al. 
1994, Dellow et al. 2001, Dellow et al. 1999).  
Regarding the sub-acute and sub-chronic effect of large doses of betaine in animals, the data 
show that trimethyl glycine is nontoxic at all doses studied and betaine is safe up to a daily 
intake of 9–15 g (average of 12 g)(Hayes et al. 2003). 
Different enzyme reactions are involved in betaine catabolism, which occurs mainly in the 
mitochondria of liver and kidney cells. The majority of these reactions involve the methionine 
cycle (Figure 5) and the transfer of methyl groups. The transmethylation reactions, vital to 
biological processes, aim to conserve methionine, detoxify homocysteine, and produce S-
adenosylmethionine (SAM), which plays an important role in maintaining the integrity of the 
liver (Barak et al. 1996). Generally, elevated total homocysteine and low SAM concentrations 
have been associated with chronic disease (Craig 2004). SAM is the methyl donor for 100 
different transmethylation reactions; it is important also for DNA methylation and protection 
from CVD, considering that aberrant DNA methylation is associated with atherosclerosis 
(Dong et al. 2003).  
Two pathways exist for the formation of methionine: via betaine or via 5-
methyltetrahydrofolate (CH3-THF). 
The first involves in liver and kidney the cytosolic enzyme betaine homocysteine 
methyltransferase (BHMT) that catalyses the methyl transfer yielding methionine and 
dimethylglycine (DMG), further metabolized to sarcosine and then to glycine. 
The second involves the enzyme methionine synthetase (MS) that transfers a methyl group to 
the cofactor cobalamin (vitamin B-12) forming methylcobalamin, which in turn transfers, the 
methyl group to homocysteine to produce methionine. The enzyme methylenetetrahydrofolate 
reductase (MTHFR) regenerates the CH3-THF from methylene-THF (Barak et al. 1996).  
BHMT, expressed in the kidney cortex and in hepatocytes in humans, pigs, and rats, is a zinc 
metalloenzyme with a distorted barrel shape and an optimum pH of 7.8 (Craig 2004), whose 
concentrations increases when diets are supplemented with betaine or choline, as shown in 
animal studies (Finkelstein et al. 1983).  
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Betaine is an important methylating agent in the liver. Even though another molecule - 
choline - is involved in the transmethylation process, its methyl groups cannot be used in 
transmethylation until they become "labile" through the oxidative conversion to betaine 
(Barak et al. 1996).  
In healthy adults, betaine increases serum methionine, transmethylation rate, homocysteine 
remethylation, and methionine oxidation (Storch et al. 1991), and in animals it was 
demonstrated an enhanced production of SAM in red blood cell, a direct methyl donor in 
many important biological pathways such as synthesis of proteins, creatine, phospholipids, 
hormones, polyamines, carnitine, adrenaline, and DNA methylation (Craig 2004). 
 
 
1.6.2 Physiological role of betaine 
Betaine is involved in the protection of internal organs, and it has been established that the 
molecule improves vascular risk factors and enhance performance.  
As osmolyte, betaine protects cells, proteins, and enzymes from environmental stress; it is an 
organic osmolyte compatible with enzyme function. Different conditions of stress, such as 
high salinity or temperature and drought, induce betaine synthesis in mitochondria leading to 
its accumulation in the cells (Craig 2004).  
Studying the effects of betaine on the structural dynamics of Thermomyces (Humicola) 
lanuginosa lipase, it was found that there is little or no binding of betaine to protein surfaces, 
allowing cells to control the surface tension of water without affecting the ionic strength of 
the environment (Soderlund et al. 2002). 
It has been suggested an important role of osmolytes in modulating immune function in 
osmotically stressed liver macrophages (Kupffer cells); betaine has a regulatory role for TNF-
α production by liver macrophages (Zhang et al. 1996 a), a modulation role of phagocytosis 
(Warskulat et al. 1996), and can reduces the induction of cyclooxygenase 2 and the increase 
of prostaglandin E2 formation (Zhang et al. 1996 b).  
Betaine protects red blood cell (RBC) against hypoosmotic stress by regulating RBC 
membrane ATPases via conformational changes (Moeckel et al.2002).  
Functioning as an organic osmolyte, betaine protects early preimplantation mouse embryos 
against increased osmolarity in vitro (Hammer and Baltz 2002), modulates the response of 
porcine endothelial cells to hypertonicity and protects them from apoptosis (Alfieri et al. 
2002).  
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In vitro, it was demonstrated that betaine affects the movement of water across the small 
intestinal epithelium; it also aids the osmoregulation of duodenal epithelium of broiler chicks 
(Kettunen et al. 2001).  
As methyl donor, betaine is implicated in the methionine cycle (Figure 5) and it is the only 
molecule - besides methylfolate - that provides one-carbon units for homocysteine 
remethylation.  
This second physiologic role is important to avoid the hypomethylation that can lead to 
disturbed hepatic protein (methionine) metabolism (in the case of elevated plasma 
homocysteine and decreased S-adenosylmethionine concentrations), and inadequate hepatic 
fat metabolism, causing plasma dyslipidemia (Craig 2004).  
 
 
1.6.3 Betaine and health effects 
 
1.6.3.1 Liver  
Many diseases, including coronary, cerebral, hepatic, and vascular diseases, can be the result 
of an impaired hepatic transmethylation process (Craig 2004).  
Nonalcoholic fatty liver disease (NAFLD) refers to a wide spectrum of liver damages, ranging 
from simple steatosis (fat accumulation) to steatohepatitis (fatty inflammation), fibrosis 
(excessive fibrous tissue), and cirrhosis (serious liver damage). NAFLD has a high prevalence 
in the general population (10-39%), and can progress to cirrhosis and liver failure (Angulo 
2002). NAFLD affects diabetics (50 percent), obese (57-74 percent), and morbidly obese 
individuals (90 percent).  
Nonalcoholic steatohepatitis (NASH) is strongly associated with the major features of 
metabolic syndrome such as obesity, central fat accumulation, diabetes, dyslipidemia 
(depressed HDL levels, elevated triglycerides), hypertension, and cardiovascular disease 
(Patrick 2002). 
It has been shown that betaine is able to mobilize hepatic cholesterol and phospholipids in 
rats, to treat hyperlipidemia, to synthesize carnitine, and to enhance the secretion of VLDL by 
methylation of phosphatidylethanolamine and generation of phosphatidylcholine (Craig 
2004). 
Abdelmalek et al. (2001) have shown that betaine is a safe and well tolerated molecule that 
leads to a significant biochemical and histological improvement (liver enzymes, steatosis, 
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necroinflammatory grade, and stage of fibrosis) in patients with NASH. Other researchers 
have concluded that betaine can be successfully employed to treat NAFLD and nonalcoholic 
steatohepatitis (NASH) (Patrick 2002, Neuschwander-Tetri 2001, Kathirvel et al. 2010, 
Angulo 2003).  
 
1.6.3.2 Heart 
Betaine is important for maintaining the heart health. Beside the improvement of non clinical 
and rather subjective parameters, such as improved sense of well-being, less fatigue, greater 
strength and endurance, and increased performance of physical and mental work, it has been 
shown improved cardiac function in subjects with cardiac deficit due to arteriosclerosis or 
rheumatic disease and congestive heart failure (Craig 2004). 
Many years ago it was proposed to treat atherosclerosis with betaine to improve the ratio of 
serum phospholipids to serum cholesterol, the sense of well-being, exercise and activity, 
appetite, angina pain, dyspnoea (shortness of breath), and libido (Craig 2004).  
Furthermore, in human studies, a low-fat, low-cholesterol diet integrated with betaine, 
choline, liver extract, and vitamin B-12 resulted in a decrease in mortality of subjects with 
atherosclerosis (Craig 2004). 
In animal studies, treatment of atherosclerosis with betaine showed a reduction in elevated 
total and ester-bound cholesterol, β-lipoproteins, total lipids in serum, and total cholesterol 
and triacylglycerols in the liver. Betaine was also shown to be implicated in the elimination of 
cholesterol through its transformation to biliary acids and intestinal excretion via the bile, and 
also to prevent the decrease of nicotinamide coenzymes and adenine nucleotides in the liver 
and myocardium (Craig 2004).  
 
1.6.3.3 Homocysteinemia 
As important methylating agent, trimethylglycine has been implicated in the treatment of, 
severe homocysteinemia and mild homocysteinemia.  
In the case of severe homocysteinemia, when remethylation defects occurs, oral betaine 
supplementation (2–9 g per day) lowers homocysteine concentrations and improves some 
clinical conditions (Ogier de Baulny et al. 1998). 
In the case of MTHFR deficiency (Holme et al. 1989, Al-Essa et al.1999, Bonig et al. 2003), 
betaine has been shown to ameliorate homocysteine remethylation, and to normalize very low 
plasma methionine and elevate SAM.  
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Betaine, at a dose of 1.5–6 g/d (Schwab et al. 2002, Steenge et al. 2003, Olthof et al. 2003), 
can decrease mild homocysteinemia with a long term effect. The same  effect was 
demonstrated for a mixture of vitamin B-6, folic acid, and betaine tested in patients with 
premature arteriosclerotic disease (Franken et al. 1994). Importantly, betaine appears to be 
highly effective in preventing the rise in plasma homocysteine concentration after methionine 
intake when compared to folic acid (Steenge et al. 2003, McGregor et al. 2002, Olthof et al. 
2003). 
In patients with renal disease, betaine can reduce postmethionine homocysteine 
concentrations but not fasting homocysteine (McGregor et al. 2002, van Guldener et al. 
1999). 
 
 
 
1.7 Choline 
Choline is a quaternary amine (Figure 6) freely soluble in water and ethanol, insoluble in 
organic solvents.  In alkaline solution it releases trimethylamine. 
 
 
 
 
 
 
 
Choline is essential for normal cell function and it plays a critical role during fetal 
development. Choline and its metabolites are important dietary sources of methyl groups. 
Taking part in the process of homocysteine methylation, choline assures the structural 
integrity and lipid transport from liver as well as signalling functions of cell membranes, and 
cholinergic neurotransmission (Zeisel and Blusztajn 1994).  
 
 
 
 
 
Figure.6 -  Structural formula of choline. 
30 
1.7.1 Choline metabolism 
 
1.7.1.1 Absorption and transport  
Choline is present in the cell membrane of all types of tissues, being an essential component 
of structural phospholipids.  
In the gut, part of the ingested free choline undergoes degradation mediated by gut bacteria, 
leading to formation of betaine and methylamines. The remaining portion is absorbed in the 
small intestine by a carrier-mediated process, which involves a saturable carrier in the brush 
border efficient at low luminal concentrations (Shils et al. 1999). When ingested as 
phosphatidylcholine, the choline is released by hydrolysis in the intestinal lumen through the 
action of phospholipases: phospholipases A2 (produced by pancreas) and phospholipases A1 
and B (intestinal mucosa) and is then absorbed as lysolecithin, which is reacylated in the 
enterocyte to yield phosphatidylcholine (Combs 2007).  
Choline is transported to the tissues mainly as phospholipids associated with plasma 
lipoproteins (phosphatidylcholine is bound to chylomicra) and the uptake into the cells is 
realized through transport systems such as Na+-dependent and Na+-independent transporters, 
or by passive diffusion. The first system is characterised by a high-affinity while the second is 
characterised by a low-affinity.  
Choline is stored as phosphatidylcholine and sphingomyelins in essential organs such as 
brain, liver, and kidney. In placenta the concentration of acetylcholine is very high, probably 
to meet the requirement of the foetus (Combs 2007).  
 
1.7.1.2 Metabolism 
In tissues, phospholipase C can cleave the phosphatidylcholine and generate diglyceride and 
phosphorilcholine, which is subsequently converted to free choline by alkaline phosphatase. 
In peripheral tissues a second enzyme implicated in phosphatidylcholine metabolism is 
phospholipase B, which generates glycerylphosphorylcholine that is further cleaved by 
glycerylphosphorylcholine diesterase yielding free choline. In the brain it is active 
phospholipase D that release the free choline from phosphatidylcholine (Combs 2007). 
Choline is irreversibly oxidized to betaine in the liver and kidney (Park and Garrow 1999). 
The enzyme choline dehydrogenase, found in the mitochondria, is involved in oxidation of 
choline to betaine aldehyde. This enzyme can also convert betaine aldehyde to betaine, though 
this reaction is mainly sustained by betaine aldehyde dehydrogenase, found in mitochondria 
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and in the cytosol. This enzyme system, namely choline oxidase, is present in some tissues, 
for example in liver and kidney, but absent from brain, muscle and blood (Combs 2007).  
 
 
1.7.2 Synthesis of phosphatidylcholine 
Choline is also utilized for the synthesis of phosphatidylcholine throug two different 
pathways. First, the cytosolic enzyme choline phosphotransferase (choline kinase) 
phosphorylates choline. In this reaction ATP serves as phosphate donor, and the resulting 
molecule, phosphorylcholine, can generate cytidine diphosphorylcholine (CDP-choline). 
Finally, after the combination of CDP-choline with diacylglycerol (mediated by 
phosphatidylcholine glyceride transferase), phosphatidylcholine is produced.  
The second alternative pathway most active in liver and also in other tissues as brain and 
mammary gland involves the sequential methilation of phosphatidylethanolamine and 
represent the main way for de novo synthesis of choline phospholipids in adult mammals 
(Zeisel and Blusztajn 1994). This reaction is mediated by phosphatidylethanolamine N- 
methyltransferase and uses SAM as the methyl donor. The enzyme is membrane-bound and 
has at least two isoforms (Zeisel and Blusztajn 1994). The cell inner membrane enzyme is 
responsible for the first methyl group transfer, and the cell outer membrane enzyme is 
responsible for the second and third methyl group transfers. In the case of deficiencies of this 
methylating enzime, the requirement for choline is higher (Combs 2007).  
Choline, in small amount, can also be transformed in the neurotransmitter acetylcholine. The 
reaction is catalized by the enzyme choline acetyltransferase, found in nervous tissues and in 
placenta, and needs the presence of acetyl – CoA and choline (Combs 2007).  
 
 
1.7.3 Choline, homocysteine, and folate 
The metabolism of choline, methionine, and methyl-folate closely interact in methionine 
formation from homocysteine. 
In one-carbon metabolism, choline can make available its methyl groups after oxydation to 
betaine. The methylation of homocysteine requires the enzyme betaine:homocysteine 
methyltransferase and betaine as methyl donor, while the alternative pathway requires 5-
methylenetetrahydrofolate:homocysteine methyltransferase and uses a methyl group derived 
de novo from the 1-carbon pool (Finkelstein et al. 1983, Zeisel and Blusztajn 1994). The 
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resulting methionine is converted to S-adenosylmetionine (the active methylating agent) by 
methionine adenosyltransferase.  
When metabolism of one of the methyl donor is perturbed, compensatory changes occurs in 
the other metabolic pattern. In animal studies, it was shown that a diet deficient in choline can 
lead to less SAM and total folate (Zeisel et al. 1989, Shils et al.1999). In human studies, a low 
folate status can lead to neural tube defects in foetus (Rush 1994). It is also important the 
interrelationship between choline and homocysteine because plasma homocysteine 
concentration represents an independent risk factor for cardiovascular disease (Clarke et al. 
1991).  
 
 
1.7.4 Functions  
Choline has an important role in the central nervous system, in the synthesis of membrane  
phosphatidylcholine and acetylcholine. Phosphatidylcholine is a structural compound of 
biological membranes, a precursor to ceramide and sphingolipids, important for 
transmembrane signalling, and a promoter of lipid transport playing and important role in 
lipid-cholesterol metabolism.  
Moreover, acetylcholine is the main neurotransmitter in the parasympathetic nervous system 
(Combs 2007).  
The platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine; PAF) is a 
choline-containing phospholipid with hormonal functions. The effect of PAF include 
activation of phosphoinositide–specific phospholipase C and release of fatty acids from 
phospholipids. This leads to subsequent generation of active metabolites, diacylglycerol and 
inositol-1,4,5-triphosphate, resulting in activation of PKC and arachidonic acid, involved in 
the formation of eicosanoids. As component of PAF, choline takes part in different biological 
functions such as activation of platelet aggregation, control of blood pressure, increase in 
vascular permeability; activation of monocytes, neutrophils and macrophages; stimulation of 
hepatic glycogenolysis. Moreover, it is also important in inflammation and allergy state and in 
childbirth induction (Zeisel and Blusztajn 1994, Combs 2007). 
Finally, as choline plasmalogens, choline molecule is important in myocardial function.  
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1.7.5 Choline deficiencies 
In humans and animal studies, a choline deficiency leads to liver dysfunction, with 
accumulation of triacylglycerol in hepatocytes (Zeisel et al. 1991, Bruni and Hegsted 1970, 
Blusztajn and Zeisel 1989, Yao and Vance 1988).  
Phosphatidylcholine is a component of very low - density lipoprotein (VLDL) (Yao and 
Vance 1988) and serve to deliver the triacylglycerols produced by the liver to tissues. When 
choline is insufficient, the synthesis of phosphatidylcholine is impaired and triglycerides 
accumulate. Methionine status can also influence the effect of choline deficiency (Combs 
2007).  
In animals, beside inducing liver dysfunction and fatty liver, choline deprivation impairs renal 
function by affecting free water reabsorption, sodium excretion, glomerular filtration rate, 
renal plasma flow, and increasing the risk of renal hemorrhage, but also infertility, depressed 
growth, hypertension, and decreased hematopoiesis (Zeisel and Blusztajn 1994). 
It has been found that choline dietary deficiency causes the development of spontaneous 
hepatocarcinomas as well as carcinogen-induced hepatocarcinomas (Zeisel and Blusztajn 
1994).  
In healthy humans a 3-week choline-deficient diet resulted in decreased plasma choline and 
phosphatidylcholine concentrations, and also in decreased plasma and erythrocyte 
phosphatidylcholine. Choline stores in tissues were depleted with the development of signs of 
liver dysfunction, i.e. increased serum alanine transaminase (ALT) activity. The authors have 
concluded that choline is an essential nutrient for humans when excess methionine and folate 
are not available in the diet (Zeisel et al. 1991). 
Different foods in human diet contain significant concentration of choline or choline esters, 
and a normal diet delivers sufficient amount. Generally, the demand for choline in normal 
adults is lower compared to the amount required in children for growth. Malnourished 
humans with poor stores of choline, methionine and folate, may also need more dietary 
choline (Zeisel and Blusztajn 1994).  
 
 
1.7.6 Health effects 
Choline can be beneficial in patients with diseases characterised by deficiencies of cholinergic 
neurotransmission. In animals, a choline supplemented diet leads to better cognitive 
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performance, increased electrophysiological responsiveness, and protection against 
neurotoxic agents and alcohol. 
Supplementation of choline in humans has shown to improve the synthesis of acethylcholine, 
helping the treatment of tardive dyskinesia (inadequate neurotransmission at striatal 
cholinergic interneurons). Choline supplementation is also associated with better memory in 
subjects without dementia as well as lower memory losses in patients with Alzheimer's 
disease, where there is a deficiency of hippocampal cholinergic neurons (Combs 2007). In a 
large population-based study, choline intake was negatively associated with anxiety 
symptoms (Bjelland et al. 2009).  
Some studies indicate that choline might be involved in the treatment of diseases such as 
hepatic steatosis or liver dysfunction (Combs 2007).  
The toxicity of choline is very low, except for the salt choline chloride which may exert a 
deleterious effect trough impaired utilization of vitamin B6 (Combs 2007).  
 
 
 
 
1.8 Dietary sources of betaine and choline 
 
In 1998, the Food and Nutrition Board of the Institute of Medicine had examined the choline 
requirements for the population and had established dietary recommendations for choline, 
estimating the intake of 550 mg / day for men and 425 mg / day for women as Adequate 
Intakes (AI) (Zeisel 2000). Generally, data on choline content in foods are sparse and 
therefore there are difficulties in estimating the levels of dietary intake. At present, for betaine 
there is no indication of Adequate Intake.  
However, some databases on the content of betaine and choline in foods have been developed 
and may be useful in providing an estimate of intake from common foods.  
Zeisel et al. (2003) have quantified both choline-containing compounds and betaine in 145 
common foods by liquid chromatography and had provided choline data for the products 
analysed under the USDA National Food and Nutrition Analysis Program (NFNAP) and for 
establish the choline USDA database.  
In their study, the authors investigated also different choline-containing compounds generally 
found in foods and tissues, such as choline, glycerophosphocholine, phosphocholine, 
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phosphatidylcholine and sphingomyelin, which can contribute to total choline intake. Foods 
such as beef and chicken liver (418 and 290 mg/100g, respectively), eggs (251 mg/100g), 
wheat germ (152 mg/100g), bacon (125 mg/100g) dried soybeans (116 mg/100g), and pork 
(103 mg/100g) were found to have the highest total choline content. Foods such as wheat bran 
(1339 mg/100g), wheat germ (1241 mg/100g), spinach (645 mg/100g), pretzels (237 
mg/100g), shrimps (218 mg/100g), wheat bread (201 mg/100g) had the highest betaine 
content (Zeisel et al. 2003).  
Later, the US Department of Agriculture, in collaboration with other institutions, created the 
USDA Database for the Choline Content of Common Foods (USDA 2008). The food sample 
units, more than 630 foods, were analysed for betaine and the choline-contributing 
compounds: free choline, glycerophosphocholine, phosphocholine, phosphatidylcholine, and 
sphingomyelin, using liquid chromatography-electrospray ionization-isotope dilution mass 
spectrometry (LC-ESI-IDMS) (USDA 2008).  
Slow et al. (2005) have examined the content of betaine and also its analogues as found in 
plants and other organisms. Beside the concentration of betaine, they measured proline-
betaine, trigonelline, and dimethylsulphoniopropionate (DMSP) in 74 processed foods from 
New Zealand. Glycine betaine was found up to 150 µg/g in grain products such as pasta, 
bread, flour; fruits (oranges and orange juice) were rich in proline betaine, coffee in 
trigonelline whereas only a small number of foods contained DMSP, though in very small 
quantities (lower than 10 µg/g)(Slow et al. 2005).  
De Zwart et al. (2003) surveyed the betaine content of a wide range of foods commonly found 
in the western diet. They also measured the content of betaine and its analogues proline 
betaine (stachydrine), trigonelline and dimethylsulfoniopropionate (DMSP). Shellfish, flour, 
and some vegetables, such as beetroot, spinach and silverbeet were a good source of glycine 
betaine. Citrus fruit, alfalfa sprouts were a source of proline betaine. Trigonelline was found 
in coffee, chickpeas, lentils and rolled oats, while DMSP was only found in some shellfish in 
important amount (De Zwart et al. 2003).  
Authors sustain that the betaine content of the same food type from different sources can be 
highly variable, depending on the way in which food had been processed or cooked and the 
stress level of the organism grown during drought, or under salt stress (Slow et al. 2005, de 
Zwart et al. 2003).  
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1.9 Betaine and choline analysis  
 
Different methods are available for quantification of betaine and choline and many of their 
analogues and multiple forms in foods and tissues. The demanding radioisotopic procedure 
has been proposed in choline and acetylcholine analysis, but later it was replaced by a 
procedure that uses high-pressure liquid chromatography (HPLC) with electrochemical 
detection (Ikarashi et al. 1985). Other accurate and inexpensive methods for the measurement 
of choline and acetylcholine include HPLC with fluorometric detection (Riccny et al. 1992) 
and HPLC with continuous-flow fast atom bombardment mass spectrometry (Ishimaru et al. 
1993). To measure other choline compounds (choline, acetylcholine, phosphocholine, and 
glycerophosphocholine) a gas chromatography/ isotope dilution mass spectrometry 
(GC/IDMS) method was developed (Jenden 1973). That method, allowing the inclusion of an 
isotopically labelled internal standard for each metabolite, assures a good accuracy even when 
different matrixes are analysed but it cannot measure betaine. A high performance liquid 
chromatography (HPLC) method for the determination of betaine in tissues, which comprises 
derivatization and HPLC separation with UV quantification has been described in the 
literature (Mar et al. 1995), as well as a liquid chromatography/mass spectrometry (LC/MS) 
method for quantification of choline and some of its metabolites (Acevedo et al. 1996). For 
the simultaneous determination of betaine, choline, and dimethylglycine in plasma a liquid 
chromatography – tandem MS (LC-MS/MS) method is available (Holm et al. 2003). Further, 
a liquid chromatography/ electrospray ionization-isotope dilution mass spectrometry (LC/ 
ESI-IDMS) method that can quantify choline, betaine, acetylcholine, glycerophosphocholine, 
cytidine diphosphocholine, phosphocholine, phosphatidylcholine, and sphingomyelin in 
various tissues and foods has been proposed by Koc et al. (2002). The LC/ESI-IDMS method 
is simpler and does not require isolation and derivatization compared to the GC/IDMS 
method (Koc et al. 2002). Recently, Graham et al. (2009) published a method for 
quantification of betaine and choline in the aleurone, bran, and flour fractions of wheat using 
NMR spectroscopy. 
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1.10 Polyphenols  
 
1.10.1 Chemical structure and food sources 
Polyphenols are secondary plant metabolites widely distributed in fruits, vegetables, and other 
plant products (Crozier et al. 2009). The skeleton of these molecules, characterised by 
aromatic rings and hydroxyl groups, are divided into several classes such as phenolic acids, 
stilbenes, flavonoids, lignans (Figure 7). A further distinction concerns the phenolic acids, 
which are classified in derivatives of benzoic acid and derivatives of cinnamic acid, and 
flavonoids that comprise flavonols, flavones, isoflavones, flavanones, anthocyanidins, and 
flavanols (Figure 8) (Manach et al. 2004). 
 
 
 
 
 
 
Figure 7. Chemical structure of polyphenols  
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Figure 8. Chemical structure of flavonoids  
 
 
1.10.1.1 Flavonoids 
The most ubiquitous class of flavonoids are flavonols, found in almost all plants, mainly as O-
glycosides. The foods with the highest content are onions, curly kale, leeks, broccoli, 
blueberries, red wine and tea (Manach et al. 2004).  
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Much less distributed in foods are flavones, most significant sources of which are parsley and 
celery. These compounds are also present in glycosylated form (Crozier et al. 2009). 
The flavanones are found in tomatoes and aromatic plants, and predominantly in citrus fruits. 
These molecules are generally glycosilated by a disaccaride, for example hesperetin-7-O-
rutinoside and narigenin-7-O-rutinoside commonly found in citrus peel (Manach et al. 2004).  
Isoflavones, presenting structural similarities to estrogens, are found almost exclusively in 
leguminose (particularly in soya).  
Flavanols range from the simple monomer (+)-catechin and its isomer (-)-epicatechin, to 
complex structures such as oligomeric and polymeric proanthocyanidins, known as condensed 
tannins. The monomers can be hydroxylated to form gallocatechins and also undergo 
esterification with gallic acid (Crozier et al. 2009). Flavanols in foods are generally not 
glycosylated. Catechins are found in fruits, whereas gallocatechin, epigallocatechin, and 
epigallocatechin gallate in seeds of leguminose plants, in grapes, and especially in tea 
(Manach et al. 2004).  
Anthocyanidins, widely distributed in plants, are responsible for red, blue, pink or purple 
colours and are present as sugar conjugates (anthocyanins). Rich sources of anthocyanins are 
fruits, especially the skin. Red wine, some varieties of cereals, and certain vegetables such as 
aubergines, cabbage, beans, onions and radishes are also a rich source of anthocyanins 
(Manach et al. 2004).  
 
1.10.1.2 Phenolic acids 
Hydroxycinnamic acids, the first class of phenolic acids, are the most common in foods. 
Important acids are p-coumaric, caffeic, ferulic, and sinapic, generally present in bound 
forms. Caffeic acid is widely distributed in all parts of fruits and ferulic acid in cereal grains. 
Chlorogenic acid, deriving from the combination of caffeic and quinic acids, are found mainly 
in coffee and also in different fruits (Manach et al. 2004).  
The second group of phenolic acids are hydroxybenzoic acids, but the concentration of these 
acids in foods are low and only some fruits, tea and onions have a significant content.  
 
1.10.2 Bioavailability of polyphenols 
The absorption into the circulatory system of flavonoids ingested with foods occurs in the 
small intestine, but only for a few components (Crozier et al. 2009). Prior to passage into the 
bloodstream as aglycons, the glycoside conjugates of flavonoids require the hydrolysis by 
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lactase phloridizin hydrolase (LPH) . LPH is situated on the brush-border of the mammalian 
small intestinal epithelial cells and possesses a specific action on flavonoid-O-β-D-glucosides. 
The released aglycone is able to enter the epithelial cells by passive diffusion as a result of its 
increased lipophilicity and its proximity to the cellular membrane (Day et al. 2000). An 
alternative route for hydrolysis appears to be mediated by a cytosolic β -glucosidase (CBG), 
which implies the transport of the polar glucosides into the epithelial cells, possibly with the 
involvement of the active sodium-dependent glucose transporter SGLT1 (Gee et al. 2000). 
However, despite some evidence on the existence of two defined way, recent research 
indicates that SLGT1 does not transport flavonoids and that glycosylated flavonoids, and 
some aglycones, have the capability to inhibit the glucose transporter (Kottra and Daniel 
2007).   
Before absorption into the circulatory system, intestinal enzymes conjugate the aglycones. 
Such metabolism includes methylation, sulfation, and glucuronidation through the respective 
action of catechol-O-methyltransferases (COMT), sulfotransferases (SULT), and uridine-5'-
diphosphate glucuronosyltransferases (UGTs). However, some of the metabolites are 
transported back into the lumen of the small intestine through the adenosine triphosphate 
(ATP)-binding cassette (ABC) family of transporters, and multidrug resistance protein (MRP) 
and P-glycoprotein (P-gp). Later, during the transport from the portal to systemic circulation, 
the metabolites are subject to phase II metabolism in the liver. Finally, the resulting 
metabolites are excreted back into the small intestine through the enterohepatic cycle (Crozier 
et al. 2009).   
If not absorbed in the small intestine, the dietary polyphenols and their metabolites that reach 
the colon are extensively metabolized by the local microbial ecosystem. The polyphenol 
metabolism consists in deglycosylation, ring fission and production of different aromatic 
acids (Van Duynhoven et al. 2010) such as hydroxyphenylacetic acids - deriving mainly from 
flavonols - hydroxyphenylpropionic acids - deriving mainly from flavanones and flavones - 
and phenylvalerolactones and hydroxyphenylpropionic acids, deriving from flavanols 
(Manach et al. 2004). These compounds can be absorbed into the colon and can be eliminated 
in the urine. 
The result of the structure and nature of the secondary metabolites compared with the native 
dietary form, and also the low concentrations that actually reach different cells, could 
determine the overall bioactivity (Crozier et al. 2009) besides the fact that the metabolites and 
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polyphenols can bind to proteins (Manach et al. 2004). In the last years many investigations 
focused on phenolic metabilites in order to gain insight on the physiological role and 
significance by taking into account the above considerations.  
It has been reported in vitro that protocatechuic acid, the main metabolite formed from 
cianidin-3-glucoside (Vitaglione et al. 2007), is a potent anticancer agent in human breast, 
lung, liver, cervix, and prostate cancer cells at concentrations lower than 10 µmol/L (Yin et al. 
2009). 
Plasma enterolactone, which derives from the colonic metabolite of lignan, has been shown to 
reduce the risk of breast (Adlercreutz 2002, Hulten et al. 2002) and prostate cancer (Stattin et 
al. 2002, Chen et al. 2007), and the risk of coronary events (Vanharanta et al. 1999).  
Interesting findings have also been found in protection of cardiovascular health by 
improvement of platelet function through the anti-thrombotic effect of some anthocyanins and 
their in vivo metabolites of colonic origin. At physiological concentrations, dihydroferulic 
acid, 3-(3-hydroxyphenyl) propionic acid, delphinidin-3-rutinoside and the mixture of all the 
compounds showed activity indicating also synergistic effect of different phenolics (Rechner 
and Kroner 2005). 
 
 
1.10.3 Polyphenols and health effects 
 
1.10.3.1 Polyphenols and CVD 
A large number of epidemiological studies demonstrate that diets rich in fruits and vegetables 
protect against the incidence of cardiovascular disease (Liu et al. 2000 a, Joshipura et al. 
2001, Lichtenstein et al. 2006, Mursu et al. 2008, Holt et al. 2009). The health effects could 
be attributed to polyphenols present in fruits, vegetables and plant products, considering the 
results of different humans and animals studies showing that the intake of these molecules 
reduces endothelial dysfunction and hypertension, dyslipidemia, atherosclerosis, 
inflammatory state, platelet activation and thrombosis (Galleano et al. 2009, Bertelli and Das 
2009, Dohadwala and Vita 2009, Corti et al. 2009, Desch et al. 2010).   
 
1.10.3.2 Mechanisms of action 
Food polyphenols represent a class of reducing agents, and a well-known mechanism 
involved in the health benefits of these molecules is the free radical-scavenging property. The 
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scavenging of free radicals consists in the reaction of one-electron donation involving the 
phenolic OH groups that reduce the radicals. In biological tissues, the main role of 
polyphenols is to protect against lipid peroxidation, which consist in the inhibition of the free 
radical chain reaction. This is considered as one of the most important antioxidant property of 
this class of molecules. 
Another action of polyphenols is the metal chelation. The capacity to sequester iron and 
copper, both involved in free radical-producing reactions, depends on the ‘‘iron chelation 
sites” that is specific for different polyphenols (Fraga et al. 2010).  
 
However the biological action of these molecules attributed to their antioxidant activity is not 
the only mechanism for body defence. Flavonoids, and also their metabolites, are able to exert 
modulatory effects in cells by interacting with intracellular signalling cascades. The 
polyphenols, selectively affect the state of different components, for example that of the 
protein kinase signalling cascades (phosphoinositide 3-kinase (PI 3-kinase), Akt/PKB, 
tyrosine kinases, protein kinase C (PKC), and MAP kinases), and are able to change the 
cellular function by altering the phosphorylation state of target molecules and/or by 
modulating gene expression (Maggi-Capeyron et al. 2001, Schroeter et al. 2005, Kong et al. 
2000, Gamet-Payrastre et al. 1999, Spencer et al. 2003, Agullo et al. 1997).  These effects are 
very important in prevention against some chronic states such as cancer, inflammation, and 
neurodegeneration. 
Maggi-Capeyron et al. (2001) have shown that wine phenolics (gallic acid, caffeic, 
protocatechic, paracoumaric, sinapic acids, ferulic acid) can inhibit the transcriptional activity 
of AP-1 (activator protein-1) implicated in the expression of a wide variety of genes involved 
in the regulation of proliferation and apoptosis and in cellular response to stress or in 
inflammation processes (Maggi-Capeyron et al. 2001). Green tea flavanols, trans-resveratrol 
and quercetin are also able to inhibit the activity of AP-1 (Aggarwal and Shishodia 2006).  
Flavanols can interact with another class of redox-sensitive transcription factor NF-kB 
(nuclear factor kappa B). Epicatechin, (+)catechin, procyanidins, curcumin and resveratrol 
can modulate the expression of numerous NF-kB-regulated genes involved in inflammation 
and carcinogenesis (Park et al. 2000, Mackenzie et al. 2004, Mackenzie et al. 2008, Manna et 
al. 2000, Crozier et al. 2009).  
Pasten et al. (2007) have reported that the polyphenols catechin and quercetin are 
cardiovascular protectors through activation of the MAPK signalling pathways and 
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consequent suppression of PAI-1 expression in human coronary artery endothelial cells in 
vitro. 
Feng et al. (2005) reported in an in vitro study molecular evidence for anticarcinogenic 
potential of chlorogenic acid through regulation of ROS-mediated NF-kB, AP-1, and MAPK 
signaling pathways. That phenolic compounds also increased the activities of detoxifying 
enzymes GST (glutathione S-transferases) and NAD(P)H quinone oxidoreductase. 
Gallic acid, p-coumaric acid and ferulic acid can regulate the gene expression of cardiac 
antioxidant enzymes in rats through increase in the levels of nuclear transcription factor 
erythroid 2p45 (NF-E2)-related factor 2 (Nrf2), an important transcription factor that 
promotes the encoding for antioxidant enzymes (Yeh et al. 2009). Curcumin and trans-
resveratrol can also activate this target for chemoprevention Nrf2 and protect the cells against 
carcinogenesis (Lee and Surh 2005). Anthocyanins, in particular malvidin, were shown to 
induce the programmed cell death in human gastric adenocarcinoma AGS cells through the 
MAPK pathway (Shih et al. 2005). 
 
 
 
1.11 Aim of the study 
Given the importance of vegetable foods in the prevention of CVD and in the maintenance of 
vascular health, this PhD researcher project was aimed to investigate the role of specific 
vegetable components, such as betaine, choline and polyphenol metabolites on different 
mechanisms putatively related to cardiovascular health. Betaine and choline are two methyl 
donors that convert homocysteine to methionine while polyphenols diminish the oxidative 
stress. 
Specifically, the work has been focused on 1) the evaluation of the role of betaine and choline 
on inflammatory markers and 2) on the role of phenolic metabolites on the modulation of 
NADPH oxidase activity, the key enzyme of oxidative stress through its role in reactive 
oxygen species production.  
In particular, the research work addressed two questions: 1) whether betaine and choline 
intake from the diet are related to inflammation, and 2) what is the effect of metabolites 
derived from berries and coffee polyphenols on the reduction of superoxide anion production 
in a cell line suitable as an in vitro model for atheroma. The two research lines hereby 
described resulted into two research papers, resumed below. 
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Paper I 
Survey on betaine and choline content in food products consumed in Italy, dietary intake and 
relation with traditional and emerging CVD risk factors. 
The aim of the work was to determine the content of betaine and free choline in products 
commonly consumed in Italy in order to estimate the daily intake in the Italian population and 
to assess the association with markers of inflammation and components of the metabolic 
syndrome in a cross-sectional study of a healthy population living in Northern Italy. 
 
Paper II 
Effect of polyphenol metabolites on superoxide anion production in cultured human 
promonocyte cells THP-1  
The aim of this in vitro study was to investigate the effect of different colonic metabolites 
derived from berries and coffee polyphenols, tested at the low concentrations actually found 
in the bloodstream after absorption, on the modulation of NADPH oxidase-dependent 
superoxide anion production in monocytes THP-1.  
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CHAPTER 2: 
Survey on betaine and choline content in food products consumed in Italy, dietary 
intake and relation with traditional and emerging CVD risk factors  
Lucia Jechiu*, Luca Calani, Francesca Scazzina, Teresa Mazzeo, Nicoletta Pellegrini, Daniele Del Rio 
Department of Public Health, University of Parma, Parma, Italy  
*Corresponding author. Tel.:+39 0521 903841; fax +39 0521 903832 
 
 
2.1 Introduction  
Cardiovascular diseases are intimately linked to inflammatory status. Different inflammatory 
biomarkers, such as C-reactive protein, interleukin-6, and tumor necrosis factor–α, have been 
related to cardiovascular risk (Cesari et al. 2003, Ridker et al. 1998) and atherosclerosis, a 
leading cause of vascular complications, is itself characterised by an increased inflammatory 
state (Ross 1999). It has been shown that homocysteine, independently associated to CVD, is 
also a factor related to subclinical inflammation (Su et al. 2005, Shai et al. 2004); the same is 
true for the metabolic syndrome that represent an important risk for CVD and, besides 
dislipidemia, insulin resistance and hypertension, is accompanied by subclinical inflammation 
(Feldeisen and Tucker 2007).  
Betaine and choline are two quaternary amines widely distributed in foods. Betaine is an 
osmolyte and a methyl donor with an important role in the protection of liver, kidney and 
heart health (Craig 2004). Choline has several biological functions, being involved in 
maintaining the integrity of cell membrane, cholinergic neurotransmission, transmembrane 
signalling and lipid metabolism (Zeisel and Blusztajn 1994). Moreover, as a precursor of 
betaine, choline represents a source of methyl groups. 
Both molecules are introduced through the diet (Slow et al. 2005, Zeisel et al. 2003) or may 
be synthesised endogenously. Choline derives from de novo synthesis (Zeisel et al. 1991) and 
can be oxidized via a two steps process to generate betaine, which can further donate its 
methyl group to homocysteine. This leads to the conversion of homocysteine into methionine 
and the subsequent generation of the methyl donor S-Adenosyl-Methionine (SAM) (Craig 
2004). 
There are few epidemiological studies considering both betaine and choline intake in relation 
to chronic diseases, mainly due to lack of food composition data (Slow et al. 2005, USDA 
46 
2008). Detopoulou et al. (2008) observed that a diet rich in betaine and choline was associated 
with a reduction of inflammatory markers in healthy adults. Betaine and choline intakes were 
inversely associated with plasma total homocysteine concentration in the Framingham 
Offspring Study (Cho et al. 2006).  
High levels of betaine have been reported in spinach, beet, bread, pasta, flour, wheat bran and 
germ. High levels of total choline have been reported in beef and chicken liver, eggs, wheat 
germ, bacon, soybean (Slow et al. 2005, Zeisel et al. 2003). Recently Graham et al. (2009) 
determined betaine and choline contents in different wheat fractions and confirmed that whole 
grain wheat contains high concentration of both molecules.  
The aim of this work was to determine the content of betaine and free choline in products 
commonly consumed in Italy in order to estimate the daily intake of these putatively 
beneficial dietary components in the Italian population and to assess the association with 
markers of inflammation and components of the metabolic syndrome. 
 
2.2 Materials and methods 
2.2.1 Italian database generation 
In order to decide the foods to be included in the composition database, as a first estimation of 
betaine and choline intake we used the IEO Italian database of food composition (Salvini et 
al. 1998) to which values on the content on betaine, free choline and total choline extrapolated 
from an USDA database (USDA 2008) were added. To this purpose, generic food items of the 
IEO database that were also present in the USDA database were assigned the USDA betaine 
and choline content. For foods for which values were expressed on moist form “as eaten” in 
the IEO database we calculated the corresponding values by applying the proportion between 
fresh and dry weight. To vegetables present in the IEO database whose values were missing in 
the USDA list, the average value of vegetables from the same family was assigned. Cooked 
foods were assigned values equivalent to their fresh counterpart. Fish products were classified 
on the fat content basis: to lean fish (fat content < 3%) was associated the value of tilapia, 
whereas to fat fish (fat content > 3%) the value of salmon. Similarly, the value reported for 
shrimps was applied to all crustaceous and shellfish categories. For meat products the values 
of beef and chicken were used, whereas for game meats such as duck, pheasant, pigeon and 
others no values were assigned. For different categories of oils, except olive oil, the value for 
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corn oil was assigned. In some cases of missing data in the USDA database, the New Zealand 
database of Slow et al. (2005) was applied. The resulting database included the content of 
betaine, free and total choline expressed as mg/100g of more than 700 foods and was then 
used to obtain intake estimates based on the food consumption data from 1240 24h recalls 
registered in northern Italy used for the validation study of the northern Italian EPIC cohort 
(Pala et al. 2003). In addition to total intake, we used the resulting data to tentatively identify 
the theoretical main food contributors for the Italian diet. 
The foods identified as potential contributors that did not have a corresponding value in the 
USDA database were then directly analysed to quantify their betaine and free choline content 
and used to integrate the missing values for the IEO database. Betaine and free choline were 
quantified in a total of 28 cereal-based products and 23 vegetables.  
Finally, the resulting complete database was applied to estimate betaine and choline intake in 
a set of food records registered in an Italian population to identify the main contributors to 
intake of betaine, free and total choline. 
 
2.2.2 Betaine and choline quantification 
Reagents and standards  
Anhydrous betaine was obtained from Fluka Biochemika (Steinheim, Germany) and choline 
base solution 50% (w/w) was obtained from Sigma (St. Louis, USA). Hexane, acetonitrile, 
formic acid, was purchased from Carlo Erba (Milan, Italy).  
Samples and sample preparation 
Cereal products, such as pasta, bread, flour, biscuits, cereals, breadsticks, toasted bread, 
crackers, focaccia, pizza, salty snacks, cakes and croissants, were analysed in a total of 28 
items. Vegetables such as spinach, beet and others were analysed in a total of 23 items. All 
products were purchased locally in supermarkets according to a sampling plan that 
considered leading brand and items for each food category. 
Before extraction, a preliminary treatment to ameliorate the homogenization and extraction 
process was performed according to the food type. Samples with non-homogeneous structure 
and high moisture (breads, sliced bread loaves, focaccia, snack, croissant, tart, Madeira cakes 
and pizza) were desiccated overnight at ambient temperature before being milled in a food 
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bread, sponge cake) were directly milled to obtain a fine granulometry. Other foods, such as 
flour, breadcrumbs and pasta were extracted without any preliminary treatment.  
For vegetables, all the products were chopped in a food processor. All samples were then 
analyzed for residual moisture content, according to AOAC standard methods. 
Betaine and choline extraction 
For the extraction, a previously published method (De Zwart et al. 2003) was adopted. After 
sample preparation, 25 g of food were weighed in triplicate and mixed with 500 ml of 
bidistilled water in a blender (Braun, Czech Republic) for 2 - 5 min. After homogenization, 5 
ml of sample were centrifuged for 10 min at 15000 x g . One ml of the supernatant was added 
with an equal volume of hexane to eliminate hydrophobic compounds and then centrifuged 
again under the same conditions. Finally, the aqueous phase was filtered through nylon filters 
(0.45µm) before HPLC MS/MS analysis. When non directly injected, samples were stored at -
80° C until analysis. To check for efficiency of extraction, three subsequent extractions on the 
residual pellets were performed and the supernatants analysed as described below.  
HPLC MS/MS analysis  
An HPLC Waters 2695(Milford, USA) equipped with a Micromass Quattromicro API triple-
quadrupole tandem mass spectrometer was used for molecular identification and 
quantification.  
Separation was carried out with a Waters Spherisorb CN 5 µm (2.1 x 250 mm) column. 
Betaine and choline were eluted with isocratic water/formic acid 1% at a flow rate of 0.25 
ml/min. Identification and quantification was performed in positive-ion mode. The source 
temperature was 120 °C, the collision gas was argon and collision energy was 14 eV. The 
capillary voltage was 3 kV and the cone voltage 30 V. The desolvation temperature was 350 
°C. 
The two molecules were analysed by Multiple Reaction Monitoring mode, with the specific 
transitions (parent mass-daughter mass m/z) of 118 - 58 for betaine and 104 - 60 for choline. 
Each sample was injected in triplicate and the results averaged. 
 
2.2.3 Subjects 
The population in this analysis included 469 healthy subjects living in the Parma area for 
which data on clinical biochemistry and functional anthropometry were gathered. Information 
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on diet was collected via 3-day dietary questionnaires. From the total 469 participants 177 
were excluded in the final analysis because of missing data and/or implausibly low food 
intake, according to the Goldberg Cutoff (Goldberg et al. 1991). The final number of 
participants with a complete dataset was 265. All volunteers gave their informed consent to 
the study, which was cleared by the local ethical committee. 
Statistical analysis 
To characterize clinical and dietary data we used descriptive statistics. We calculated the 
mean intake and the main food contributors for betaine and choline by linear regression 
analysis, then we assessed the association between betaine, free choline and total choline and 
intermediate CV risk markers by GLM analysis, using as predictor variables the quartiles of 
intake of betaine, free and total choline after adjustment for energy intake with the residual 
method (Willet and Stampfer 1986). 
Further assessment of the association between inflammation markers and betaine or choline 
intake was done by Univariate ANOVA including potential confounding variables known to 
influence inflammatory markers, i.e. age, post-load plasma glucose, total antioxidant capacity 
(TEAC), dietary fibre, Glycemic Index (GI), ALT and AST transaminases, alkaline 
phosphatase and total leucocytes (Bermudez et al. 2002, Hanley et al. 2005, Kazumi et al. 
2006, Fredrikson et al. 2004, James et al. 2000, Liu et al. 2002, Fröhlich et al. 2000, 
Bisoendial et al. 2009, Yen et al. 2006, Brighenti et al. 2005, Oliveira et al. 2009). 
All statistical analyses were performed using the statical package, SPSS 17.0 . 
 
 
2.3 Results 
2.3.1 Preliminary study: betaine and choline intake in the EPIC cohort  
The Italian database contains 789 foods of which only 76 did not receive an associated value 
from literature. The application of this preliminary database to the 1240 24h food records 
from the EPIC validation study allowed a first rough estimate of the theoretical mean content 
of the 3 molecules in different food groups. Betaine was found at high levels in cereal 
products (52,69 mg/100g) and vegetables (29,60 mg/100g); free choline was found at high 
levels in offal (48,54 mg/100g) and legumes (40,07mg/100g), while total choline in eggs 
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(462,43mg/100g) and offal (274,59 mg/100g). The main contributors to betaine and choline 
intake in this free-living population were cereal products, fresh fruits, canned foods, juices 
and vegetables. The mean betaine intake was (mg/day) 196±94; the mean free choline intake 
was 73±23, and the mean total choline intake was 266±83. The women had lower intake then 
men but this difference disappeared after adjustment for energy intake. Examining the food 
contributors for betaine and choline, cereal products (semolina pasta and bread) and 
vegetables (spinach and beetroot) resulted the main contributors to betaine intake. The main 
contributors to free choline intake resulted bread, pasta and red whine, while the main 
contributors to total choline resulted eggs, bread and meat.  
 
2.3.2 The betaine and choline content in foods. Database integration 
We included in our database the betaine and free choline content of foods identified as major 
contributors and some variety of vegetables mostly consumed in Italy: 28 cereal (Table 1) and 
23 vegetable products (Table 2).  
Extraction of betaine and choline from foods and HPLC-MS/MS analysis 
The applied extraction volume and the removal of lipophilic compounds ensured an 
exhaustive extraction of analytes (98.2±0.14% for betaine and 96.7±0.38 % for choline, n=3). 
A one step procedure allowed a better accuracy and precision. 
Figure 1 shows the chromatograms of standards. An example chromatogram of betaine and 
choline in a bread extract is reported in Figure 2.  
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Figure 1. Typical (MRM) chromatograms of betaine ( m/z 117.9 ) and choline (m/z 103.88) 
reference standards. 
 
 
 
 
 
 
 
 
 
 
Figure 2. Typical chromatogram of betaine (m/z117.9) and choline (m/z 103.88) in a wheat 
bread  “type 0” sample. 
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Betaine and free choline content of foods 
The betaine and free choline content of the foods analysed are shown in Table 1 and Table 2. 
All data are reported in mg/100g of edible portion (Fresh Weight).  
 
Table 1. Content of betaine and free choline in cereal food products¹ 
Food  Betaine  
(mg/100g FW) 
Choline 
(mg/100g FW) 
 Pasta 
 Pasta (penne), cooked 
 
77.5 ± 1.6 
 
6.2 ± 0.3 
 Pasta (fusilli), cooked 74.7 ± 1.3 8.5 ± 0.2 
 Fresh egg pasta, cooked 49.7 ± 0.4 7.3 ± 0.3 
 Pasta, whole-wheat, cooked 91.0 ± 0.5 13.2 ± 0.3 
 Dry egg pasta, cooked 41.1 ± 1.1 32.0 ± 2.2 
 Bread  
 Bread, white 
 
51.1 ± 0.5 
 
14.4 ± 0.1 
 Milk bread 53.2 ± 0.5 14.6 ± 0.3 
 Bread, common 62.7 ± 1.0 14.2 ± 0.4 
 Bread, whole-wheat 103.9 ± 2.1 18.2 ± 0.6 
 Sliced loaves 51.8 ± 0.9 11.3 ± 0.4 
 Breadcrumbs 
 Baked products and flour 
 Melba toast 
 Melba toast, whole-wheat 
 Cracker, salted 
 Pizza (plain baked dough, with tomato sauce) 
81.6 ± 1.9 
 
79.3 ± 2.1 
135.5 ± 6.8 
42.3 ± 1.6 
36.3 ± 0.8 
19.6 ± 0.1 
 
18.2 ± 0.7 
21.5 ± 0.5 
16.0 ± 0.1 
14.5 ± 0.0 
 Pizza (thin with cheese and tomato sauce) 29.5 ± 0.4 16.4 ± 0.2 
 Focaccia 35.0 ± 0.6 9.9 ± 0.2 
 Breadstick 
 Flour, wheat, “type 00” 
46.2 ± 1.8 
93.3 ± 4.1 
11.2 ± 0.3 
10.7 ± 0.2 
 Breakfast cereals and cakes    
 Cornflakes (maize, brown rice, whole-wheat) 50.3 ± 3.9 12.9 ± 0.4 
 Frollino cookie, whole-wheat 66.9 ± 5.7 11.8 ± 0.2 
 Frollino egg cookie 39.9 ± 1.5 9.4 ± 0.2 
 Cookies (low fat) 34.5 ± 0.9 7.5 ± 0.2 
 Sponge cake 25.0 ± 1.0 6.9 ± 0.2 
 Tart (no jam) 25.4 ± 0.8 7.5 ± 0.1 
 Cake Margherita 10.6 ± 0.2 4.0 ± 0.2 
 Sponge cake (wheat, oat, barley), cherry 
jam 
34.8 ± 1.3 9.8 ± 0.3 
 Croissant 29.4 ± 1.6 10.8 ± 0.2 
¹Values are reported as mean ±SD, n=3. 
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The betaine and choline content of cereal samples ranged from 10.6 mg to 135 mg and from 4 
mg to 32 mg per 100g of food (FW), respectively. Wholemeal foods contained higher levels 
of betaine and choline with respect to refined foods, in agreement with the findings of Zeisel 
et al. (2003) and Graham et al. (2009).  
 
Table 2. Content of betaine and free choline in vegetable products¹ 
Food  Betaine 
(mg/100g FW) 
Choline 
(mg/100g FW) 
Field mushroom Agaricus campestris  29.3±1.38 7.3±0.10 
Fennel Phoeniculum vulgare 0.0 11.1±0.07 
Beetroot Beta vulgaris L. var. cruenta L. 
Salisb 
667.2±36.62 4.8±0.35 
Spinach Spinacia oleracea L. 195.4±6.94 9.2±0.2 
Beta vulgaris L. var. cycla (L.) Ulrich 182.6±8.93 9.5±0.36 
Beet Beta vulgaris L. var. cycla (L.) Ulrich 233.5±17.72 12.9±1.14 
Tomato Pachino 0.0 4.5±0.07 
Tomato Ramato 0.0 2.4±0.14 
Tomato ripe 0.0 3.0±0.07 
Tomato S. Marzano 0.0 3.4±0.18 
Tomato, without peel, canned  0.0 5.7±0.9 
Chicory Witloof Cichorium intybus, cv 
witloof 
0.0 1.9±0.01 
Chicory Catalogna Cichorium intybus, cv 
catalogna 
tr2 12.1±0.19 
Cichorium intybus Chioggia  0.0 10.2±0.32 
Cichorium intybus Radicchio  tr2 13.7±0.28 
Carrot Daucus carota 0.0 2.0±0.16 
Cabbage Brassica oleracea cv capitata 0.0 6.0±0.09 
Onion Allium cepa 0.0 3.4±0.24 
Lettuce Lactuca sativa 0.0 4.2±0.21 
Courgette Cucurbita pepo tr2 12.5±0.17 
Pepper Capsicum annuum tr2 8.4±0.29 
Aubergine Solanum melongea  0.0 2.0±0.12 
Potatoes tr2 28.2±1.68 
¹ Values are reported as mean ±SD, n=3. 
2 Traces, value <1. 
 
Concerning the betaine and choline content of vegetables, there is a uniform distribution of 
choline, while betaine is present either in trace or in huge amounts in different vegetables. 
Further, as previously noticed, the same family of vegetables contains approximately the same 
betaine amount. For example Chenopodiaceae are rich in betaine.  
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2.3.3 Association of betaine and choline intake with intermediate risk factors for CVD 
 
Population characteristics and estimated intake in the Italian diet. 
Table 3 shows the clinical characteristics of the study participants. The subject’s sample of 
125 female and 140 male was aged 51±11 and 56±13 y respectively and had a BMI (kg/m²) of 
25.52±3.75 with an SBP and DBP of 131±21 and 83±13 (mean ± SD) (Table 3). The 
descriptive statistic of energy and nutrient intakes and food sources are reported in Table 4 
and Table 5. 
 
Table 3. Characteristics of the population 
 
 Gender  
 Female (125) Male (140) Total (265)  
 Mean SD  Mean SD  Mean SD 
Age 51 11  56 13  54 12 
Weight 64,1 10,6  78,1 12,1  71,5 13,4 
BMI 24,87 4,10  26,11 3,32  25,52 3,75 
Waist 88 10  94 10  91 11 
Systolic blood pressure (mm Hg) 123 18  138 20  131 21 
Diastolic blood pressure (mm Hg) 78 13  88 11  83 13 
Fasting glicaemia (mg/dL) 88 10  96 10  92 10 
Serum insulin (mU/L)  7,4 3,9  8,6 4,5  8,0 4,3 
HDL cholesterol (mg/dL)  69 15  57 14  63 15 
Triglycerides (mg/dL) 74 39  93 51  84 46 
C-reactive protein (mg/L)  2,3 3,2  3,2 4,9  2,8 4,2 
Physical activity level PAL  1,72 0,28  1,67 ,27  1,70 ,28 
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Table 4. Descriptive of nutrient intake  
 Gender 
 Female Male Total 
 Mean SD  Mean SD  Mean SD  
Energy (kcal) 2151,37 350,76  2656,94 409,34  2418,46 458,20  
Carbohydrates (% of 
energy) 
49,43 6,42  48,75 6,40  49,07 6,40  
Protein (% of energy) 14,69 2,39  14,42 2,24  14,55 2,31  
Fat (% of energy) 34,87 5,01  31,84 4,83  33,27 5,13  
Sugars (g) 96,33 28,91  99,81 32,68  98,17 30,95  
Total fibre (g) 19,4 7,17  22,32 6,59  20,94 7,01  
Total fats (g) 83,87 19,08  94,05 19,46  89,25 19,90  
Saturated fat ( % on 
total) 
35,80 5,03  35,00 5,14  35,38 5,09  
Monounsaturated fat (% 
on total) 
50,91 4,72  51,39 4,76  51,16 4,74  
Polyunsaturated fat (% 
on total) 
13,29 2,73  13,61 3,29  13,46 3,04  
Cholesterol (mg) 299,95 96,98  336,18 128,54  319,09 115,95  
Alcohol (g) 12,23 11,36  30,51 20,31  21,88 19,01  
Vitamin C (mg) 119,78 62,75  133,73 72,48  127,15 68,30  
Beta-carotene (µg) 2949,49 1529,61  3249,89 1990,59  3108,19 1791,04  
Vitamin E (mg) 11,01 3,31  11,83 3,55  11,44 3,45  
Folate (µg) 277,94 86,16  314,97 92,97  297,50 91,54  
Betaine (mg/day) 193,61 66,77  262,70 83,76  230,11 83,56  
Free choline (mg/day) 83,20 22,09  107,18 24,84  95,87 26,42  
Total choline (mg/day) 255,18 69,31  313,39 85,90  285,93 83,6  
 
Table 5. Descriptive of food sources (grams/ day) 
 Gender 
 Female Male Total 
 Mean SD Mean SD Mean SD  
Sweets, cakes, biscuits 108,02 65,55 97,85 59,32 102,65 62,43  
Bread, pizza 140,46 60,50 181,86 81,29 162,33 75,01  
Cereals, flours 69,90 37,32 105,6 51,17 88,76 48,50  
Legumes, potatoes 47,46 48,40 59,75 68,75 53,95 60,22  
Sweets, cakes 88,45 64,01 75,98 53,64 81,86 58,98  
Alcoholic beverages  135,6 119,6 320,2 211,5 232,8 196,8  
Chocolate  3,6 4,9 3,1 8,7 3,3 7,1  
Cheese  45,6 27,2 45,1 25,5 45,4 26,3  
Fruits  248,1 138,0 260,7 155,8 254,8 147,5  
Dry fruits  2,5 4,9 2,5 6,6 2,5 5,9  
Milk  137,9 104,2 135,9 116,0 136,9 110,4  
Fish 15,1 26,1 13,2 33,3 14,0 30,1  
Soft-drink 25,1 59,9 25,9 61,8 25,5 60,8  
Fruit juices  37,1 68,7 44,7 91,1 41,1 81,3  
Spices  1,3 1,9 1,4 2,8 1,4 2,4  
Eggs  12,8 14,6 13,7 16,5 13,3 15,6  
Vegetables  191,7 98,5 215,4 98,8 204,2 99,2  
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There were significant differences in the consumption of some food items in males and 
females. The highest consumption of bread and pizza, cereals and flours, and alcoholic 
beverages was observed in men (Table 5). Also, significant differences between males and 
females were noticed in the case of energy, energy from fat, total fibre, total fats, cholesterol, 
and alcohol (Table 4). The mean daily intake (mg) for betaine, free choline and total choline, 
were respectively 230.11±83.56, 95.87±26.42, 285.93±83.60. The mean quartile intakes 
varied from 149.81 to 320.71 mg/d for betaine, from 74.94 to 121.80 mg/d for free choline, 
and from 206.77 to 376.46 mg/d for total choline.  
Dietary intake of betaine was predicted by the consumption of cereal products and flours, 
bread and pizza, fresh and cured meat, vegetables and milk (40% of total intake). Free choline 
intake was predicted by a wider range of foods, such alcoholic beverages, legumes and 
potatoes, bread and pizza, vegetables, fruits, milk, dry fruits and cereal- flours with a total 
contribution of 63%. For total choline, the highest predictors were eggs and egg products, 
followed by fresh and cured meats, alcoholic beverages, legumes and potatoes, milk, fish, 
fruits and other foods, for a total contribution of 56% (Table 6). Given that foods with the 
highest betaine content are wheat bran and germ, spinach, beets, and wheat bread, while foods 
with the highest total choline content are beef and chicken liver, eggs, wheat germ, these 
relations seem reasonable. 
 
Table 6. Food contributors to betaine, free choline and total choline 
 
Betaine  Free Choline  Total Choline  
Food Cumulative 
percentage  
Food Cumulative  
percentage 
Food Cumulative  
percentage 
Cereal and 
flours 
18.3 Alcoholic 
beverages 
19.7 Eggs 20.5 
Bread and 
pizza 
35.7 Legumes and 
potatoes 
33.5 Fresh and cured 
meats 
28.7 
Fresh and 
cured meat 
37.5 Bread  
and pizza 
45.7 Alcoholic 
beverages 
35.0 
Vegetables 38.9 Vegetables 55.0 Legumes and 
potatoes 
41.1 
Milk 39.6 Fruits 59.2 Milk 45.3 
  Milk 61.0 Fish 49.0 
  Dry fruits 62.3 Fruits 53.0 
  Cereals 
and flours 
63.3 Vegetables 54.1 
    Bread and pizza 55.1 
    Fruit juices 55.8 
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Association of betaine and choline intake with components of the metabolic syndrome 
In this study, betaine intake showed a positive and significant association with waist girth, 
DBP, glycaemia at 60 min after glucose challenge, plasminogen activator inhibitor-1 (PAI-1), 
and C-reactive protein (CRP). Free and total choline intake did not show associations. 
Choline and betaine were not associated with any of the following variables: fasting 
glycaemia and insulinaemia, HDL, Triglycerides, AST and ALT, fibrinogen, and TNF-α. All 
these associations were not changed after stratification for sex, whereas we found a positive 
association after introducing the new variables  energy from carbohydrates, folates, glycaemic 
load, and a negative association with energy from fats, vitamins C and E (Table 7).  
Further, after adjustment for covariates, betaine intake was positively associated with CRP 
(Table 8), the following covariates resulting significant (p <0.05): age, glucose 120, TEAC, 
AST, ALT, polyunsaturated fatty acids and leucocytes, with a total contribution of 
(R²)=26.5%.  
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Table 7. Characteristics of the population by percentile group of betaine  
 
 1st quartile  2 nd quartile 3 rd quartile 4 th quartile 
 Mean § SE Mean & SE Mean £ SE Mean $ SE 
Age 54 1 53 2 53 2 55 1 
BMI 25,61 ,46 24,71 ,43 25,44 ,42 26,35 ,52 
Waist 91 1 88 1 92 1 94 & 1 
SBP(mm Hg) 132 2 127 2 129 3 135 3 
DBP(mm Hg) 85 1 79 2 82 2 88 & £ 2 
Glycaemia (mg/dL) 91 1 91 1 92 1 95 2 
Post-load plasma glucose 
(60 min) (mg/dL) 
122 5 136 5 130 4 145 § 6 
Post-load plasma glucose 
(120 min)(mg/dL) 
92 3 102 4 95 3 102 5 
Insulinaemia (mU/L) 8,4 ,6 6,9 ,4 8,3 ,4 8,6 ,6 
Total cholesterol (mg/dL) 220 5 211 5 218 5 225 5 
HDL-cholesterol (mg/dL) 66 2 62 2 62 2 61 2 
Triglycerides (mg/dL) 82 6 76 5 86 6 92 6 
AST transaminase (U/L) 24 1 22 1 24 1 26 2 
ALT transaminase (U/L) 23 1 22 1 24 2 27 2 
Plasminogen activator 
inhibitor - 1(ng/mL) 
13,71 1,21 10,32 ,83 14,51 1,19 15,24 & 1,27 
C-reactive protein (mg/L) 2,2 ,3 2,3 ,5 2,4 ,4 4,2 § ,7 
Betaine (mg/d) 149,81 3,99 204,06 § 1,23 241,06  
§ & 
1,57 320,71 
§ & £ 
5,61 
Carbohydrates (% of 
energy)  
46,73 ,83 48,26 ,70 50,60 § ,78 50,67 § ,74 
Protein (% of energy)  13,96 ,27 14,48 ,30 14,80 ,30 14,95 ,26 
Fats (% of energy)  35,80 £ $ ,60 34,60 £ $ ,62 31,85 ,55 30,86 ,57 
Total fibre (g)  20,25 ,91 19,71 ,81 21,14 ,88 22,67 ,81 
Alcohol (g)  22,43 1,99 19,87 2,19 20,68 2,37 24,57 2,74 
Vitamin C (mg)  146,67 £ 10,73 122,81 7,75 110,16 7,11 129,21 7,00 
Beta-carotene (µg)  3239,79 240,61 3111,97 237,90 2808,74 196,55 3276,79 202,45 
Vitamin E (mg)  12,53 £ ,52 11,42 ,38 10,70 ,38 11,13 ,38 
Folates (µg)  307,86 13,55 277,48 9,84 282,30 9,32 322,59 
& 
11,17 
Glycemic load (g eq) 164,15 5,12 158,82 4,73 167,03 5,37 180,72 
& 
4,69 
Glycemic Index  57,81 ,43 56,57 ,39 56,55 ,44 56,53 ,43 
Total antioxidant 
capacity (mmol ) 
6,54 ,40 5,68 ,27 6,03 ,29 6,05 0,28 
Significantly different <0.05 from; §: first quartile; &: second quartile; £: third quartile; $: fourth quartile; SE: 
Standard error. 
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Table 8. Betaine association with CRP after adjustment for covariates 
 
Source Sum of the square df Mean of the square F Sig. 
Adjusted model  1277,42 13 98,263 7,870 ,000 
Intercept 162,852 1 162,852 13,042 ,000 
Quartile of Betaine  104,657 3 34,886 2,794 ,041 
Covariates:      
Age (y) 287,043 1 287,043 22,989 ,000 
Post-load plasma glucose 
(120 min)(mg/dL) 
88,474 1 88,474 7,086 ,008 
Total antioxidant capacity 
(mmol vitE/L) 
99,610 1 99,610 7,978 ,005 
Glycemic Index (%) 35,397 1 35,397 2,835 ,094 
AST (U/L) 86,223 1 86,223 6,905 ,009 
ALT (U/L) 70,699 1 70,699 5,662 ,018 
Polyunsaturated fatty acids  
(% of energy) 
108,015 1 108,015 8,651 ,004 
WBC  347,082 1 347,082 27,797 ,000 
Error 2934,267 235 12,486     
Total  6070,017 249       
Adjusted total 4211,689 248       
 
 
 
 
2.4 Discussion 
 
In this study we developed an Italian database on the betaine and choline content of common 
foods. This included molecular quantification for more than 40 food items, which allowed us 
to better characterise the Italian population and to study the correlation between betaine and 
choline intake and CVD risk factors. Cereal products are a good source of betaine and free 
choline, ranging from10.6 mg to 135 mg and from 4 mg to 32 mg per 100g of food (FW), 
respectively. In particular wholemeal foods contain higher levels of betaine and choline with 
respect to refined foods. In vegetables, choline is widely distributed while betaine was found 
at high levels in vegetables of Chenopodiaceae family as beetroot (667.2 mg/100g) and 
spinach (195.4 mg/100g). Comparing betaine content with data reported in other databases, 
some difference can be noted. For example, the betaine content (mg/100g FW) of white and 
whole-wheat bread in the USDA database is 31 and 38, while the content for refined and 
whole-wheat bread in this study is 62.7 and 103.9, respectively. De Zwart et al. (2003) found 
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that pasta has an average betaine content of 35.2 mg/100g, whereas betaine content in pasta 
samples considered in this study is about 2 folds higher. The content of beetroot are higher in 
our study relative to USDA data (130 mg/100g). Generally it must be considered that betaine 
content can vary in foods and some factors able to influence the concentration include 
growing and osmotic stress conditions of crops (Craig 2004), food processing (De Zwart et al. 
2003) as well as the variety of grain and the milling systems (Likes et al. 2007). This 
underlines the importance of national databases with the molecular content of local foods. 
Regarding intake data, the strength of this work is the use of a database specifically designed 
to include molecular content of the national foods, and the use of diet records, which give a 
more accurate estimate of food consumption compared to food frequency questionnaires. 
In the present survey on 265 persons we found that the mean daily intakes were of 
230.11±83.56, 95.87±26.42, and 285.93±83.60 for betaine, free choline and total choline, 
respectively. Beside the mean intake of betaine and free choline, we assessed the amount of 
total choline considering that the molecule in foods can be present bound as esters in 
phosphocholine, glycerophosphocholine, sphingomyelin, and phosphatidylcholine. 
Comparing the dietary intake with some data from literature we found a lower intake with 
respect to a Greek population for betaine and total choline (Detopoulou et al. 2008). In a 
sample of New Zealanders, betaine intake has been reported higher than in our Italian sample 
(Slow et al. 2005). Finally, it can be noticed that choline intake in our participants is lower 
than the Adequate Intake, given that the level for choline (Zeisel et al. 1991) is 550 mg/d for 
men and 425 mg/d for women. Choline is widely present in foods and we found that choline 
intake derives from a great number of food items, whereas for betaine the main food sources 
in the Italian diet are almost limited to cereal products. In a New Zealand population the 
intake of betaine is also attributed to grain-based products (Slow et al. 2005), whereas in a 
Greek population consuming a Mediterranean diet, it was attributed to vegetables (particularly 
spinach) and legumes (Detopoulou et al. 2008).  
 Relevant findings from our study are that betaine intake was positively associated with 
component of the metabolic syndrome (Eckel et al. 2005). These factors are waist girth, DBP, 
glycaemia at 60 min after glucose challenge, but also PAI-1 and CRP that, while not part of 
the metabolic syndrome definition, are normally associated with insulin resistance. Further, 
the highest quartile of betaine intake had higher energy from carbohydrates, folates and 
glycaemic load, and less energy from fats, vitamin C and E. After adjustment for covariates, 
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betaine intakes were positively associated with the inflammatory biomarker C-reactive 
protein, an independent risk factor of cardiovascular events (Li and Fang 2004).  
Choline and its metabolite betaine are two important methyl–donors involved in the 
transformation of homocysteine to methyonine (Craig 2004, Zeisel and Blusztajn 1994). 
Supplementations with high doses of betaine (1.5-6 g/day) or choline (2.6g/day) decreased 
plasma homocysteine, as shown in intervention studies in healthy population (Steenge et al. 
2003, Olthof et al. 2003, Olthof et al. 2005). Cho et al. (2006) assessed the relation between 
dietary choline and betaine and plasma total homocysteine in 1960 subjects, finding that 
higher dietary intakes were related to lower homocysteine. The effects of dietary choline and 
betaine were studied on different inflammatory biomarkers. Detopoulou et al. (2008) reported 
that higher dietary intakes of choline and betaine in a Greek population reduce several 
biomarkers of inflammation. In the cross-sectional ATTICA study, with more than 3000 
persons, the authors found that plasma C-reactive protein, interleukin-6, and tumor necrosis 
factor-α concentrations in the highest tertile were significantly lower that in the lowest tertile 
of betaine and choline intake. For betaine it was also found that participants with the highest 
consumption had lower concentration of homocysteine (Detopoulou et al. 2008). 
Despite many evidences in cardiovascular protection, some other studies with different 
outcomes must be considered. The EPIC cohort demonstrated no relation of dietary intake of 
choline or betaine with cardiovascular disease risk (Dalmeijer et al. 2008). The ARIC study 
showed no relation between dietary choline or choline plus betaine and incident coronary 
heart disease (Bidulescu et al. 2007). The results of these two large-scale studies are not far 
from our study, considering that we also found no association for choline. The low dietary 
range of the molecular intake, as suggested by Dalmeijer et al.(2008), can represent a possible 
hypothesis of these association. In our population the intake is also low and similar to the 
intake revealed in the participants from EPIC cohort (Dalmeijer et al. 2008).  
There are many potential mechanisms that concern the consumption of diets lower in choline 
and betaine and increase in biomarkers of inflammation and cardiovascular risk in healthy 
humans. Beside the methylation and the removal of homocysteine, it can be included the 
pathway of under-methylation of DNA, when the low dietary intakes of choline and betaine 
alter epigenetic regulation of genes that accelerate the atherogenic process (Dong et al. 2002, 
Zaina et al. 2005). It has also been reported that choline deficiency is associated with leaky 
mitochondria, major leakage of reactive oxygen species and DNA damage (Vrablic et al. 
2001, Da Costa et al. 2006), leading to increased state of inflammation. Detopoulou et al. 
62 
(2008) hypothesise that inflammation can be reduced by increasing S-adenosylmethionine 
(SAM) and decreasing S-adenosylhomocysteine (SAH). 
Metabolic syndrome is linked to dietary intake and recognises protective the 'healthy' pattern 
(Feldeisen and Tucker 2007, Esmailzadeh et al. 2007). In this study the major betaine 
contributors were cereal products such wheat pasta, white bread, but not whole foods. 
Furthermore, compared with the lowest quartile of betaine intake, participants who consumed 
>320 mg/100g in the highest quartile had higher intake of energy from carbohydrates, folates, 
glycaemic load and the lowest intake of energy from fats, vitamins C and E. Given that the 
major food contributors to betaine intake are cereal products, it can be argued that the inverse 
association between betaine intake and component of metabolic syndrome might at least 
partially depend on diet and might be attributable to consumption of refined wheat, known be 
associated with the development of metabolic syndrome (Feldeisen and Tucker 2007).  
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CHAPTER 3: 
Effect of polyphenol metabolites on superoxide anion production in cultured human 
promonocyte cells THP-1  
 
 
3.1 Introduction  
 
Atherosclerosis is a multifactorial chronic disease accompanied by chronic low-grade 
inflammation (Ross 1999). A characteristic of this inflammatory state consists in the damage 
of the vascular endothelial and smooth muscle cells, sustained by reactive oxygen species 
(ROS). As a consequence, anticoagulant, anti-inflammatory and vasorelaxation properties of 
the endothelium are impaired whereas dysfunction arises from the recruitment of monocytes, 
macrophages, growth factors, with generation of atherosclerotic plaques (Seifried et al. 2007). 
It has been shown that the superoxid anion O2°- and its metabolites are involved in smooth 
muscle cell proliferation (Hidaka et al. 1992), endothelial dysfunction such as increased 
vascular permeability, and leukocyte adhesion (Lum and Roebuck 2001) increasing CVD 
risk. The leading system responsible for O2°- production is NADPH oxidase, present in 
leukocytes and vascular cells (Chanock et al. 1994). 
Antioxidants have been shown to protect cells against superoxide anion production through at 
least two distinct processes: direct free radical scavenging or modulation of cell free radical 
generation through regulation of NADPH activity in monocytes (Cachia et al. 1998). For 
example, polyphenol mixtures from olive oil wastewaters decreased superoxide anion 
production by scavenging and depressing O2°- in a model of human macrophages implicated 
in atheroma (Leger et al. 2000). Shafiee et al. (2003) found that polyphenols from grape seed 
rich in procyanidins lowered superoxide anion production in THP1 cells.  
The inhibition of the release of reactive oxygen species was also demonstrated in other cell 
models, for example in human neutrophils (Limasset et al. 1993).  
Therefore, endothelial NADPH oxidase could represent a candidate target of dietary 
flavonoids, and particularly of their metabolites. Steffen et al. (2008) have reported that in 
human endothelial cells only the O-methylated metabolite of (-) epicatechin results in a 
decrease in superoxide anion production, while its native parent polyphenol proved to be an 
O2°- -scavenger that did not inhibit NADPH oxidase activity.  
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This is one of the few works that investigates the effects of polyphenol metabolites on O2°- 
inhibition and in particular on NADPH oxidase activity. In previous works on monocytic cell 
no research has taken into consideration the effect of polyphenol metabolites but only that of 
the parent compounds as present in food sources. 
Moreover, polyphenols are normally studied as aglycones and sugar conjugates presented to 
cells at non-physiological concentrations, rather than metabolites at low concentration levels, 
as they actually occur in the circulatory system. Probably, to identify the true bioactivity 
effects of polyphenols, we should research the effect of phenolic metabolites formed in the 
small intestine and hepatic cells, and the catabolic products of the colonic microflora (Crozier 
et al. 2009). 
Accordingly, the aim of our study was to investigate the effect of some colonic metabolites on 
the modulation of NADPH oxidase-dependent superoxide anion production in monocytes 
THP-1, a cell line implicated in atheroma. We focused our research on the catabolites 
deriving from the metabolism of coffee and berry, two food sources known to have a high 
content of antioxidants (Gomez-Ruiz et al. 2007, Halvorsen et al. 2006), working at 
physiological concentrations. We also investigated the synergistic effect of the molecules 
deriving from the same parent compound by testing their mixtures.  
 
 
3.2. Materials and methods 
We tested on the THP-1 cell line the molecules Dihydrocaffeic acid (DHC), Dihydroferulic 
acid (DHF), Feruloylglycine (FG) individually at 3µM and as a mixture at 9µM; 
Protocatechuic acid (PA), 3-(3-hydroxyphenyl) propionic acid (33HPP), Homovanillic acid 
(HVA), 3-hydroxyphenylacetic acid (3HPA) at 5 µM and 20 µM as mixture formulation. 
 
3.2.1 Chemicals and reagents  
All culture reagents were purchased from Gibco (Paisley, UK). Lucigenin, phorbol 12-
myristate 13-acetate (PMA), and differentiation agents were obtained from Sigma (St. Louis, 
MO, USA). DHF, DHC, PA, HVA, 3HPA, were purchased from Sigma Aldrich Co. (St. 
Louis, MO,USA). FG were obtained from TAKAO, 33HPP were supplied by 
FLUOROCHEM (Derbyshire, UK). The ethanol utilized for dissolution of the molecules was 
obtained from Carlo Erba, Milan.  
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3.2.2 THP-1 cell culture and in vitro test with polyphenol catabolites  
Catabolites were tested together, according to the class of native molecules, on a line of 
human THP-1 monocytes obtained from a human diffuse hystocytic lymphoma. 
DHC, DHF, FG, derived from coffee phenolic catabolism, were prepared as a solution to 
obtain a final concentration of 3µM for each metabolite. When tested all together, the total 
concentration in the plate was 9µM. The second group of molecules, PA, 33HPP, HVA, 
3HPA were prepared to reach a final concentration in the medium of 5µM and 20 µM 
respectively for single metabolite and mix formulations.  
The cell cultures were grown at a concentration of 2.0 – 2.5 x 105 cells/ml in RPMI 1640 
GLUTAMAX red phenol supplemented with SVF (10%), Fungizone (0,05%), 
Penicillin/Streptomycin (1%) in an humidified incubator (5% CO2) at 37°C. The medium was 
changed every 2nd and 3rd day. The differentiation of promonocytes to monocytes was 
induced with retinoic acid (1mM), 1,25 dihydroxycholecalciferol (0,1mM), and interferon-γ 
(100UI/µl) at a concentration of 3.0 x 105 cells/ml. After 72h, the differentiated cells, 
adherent and unable to proliferate, were changed of medium and added in a Petri plate with 
different test catabolites alone or in mix and incubated for 3 and 24h. For each food, 
catabolites were tested under the same conditions.  
To establish the optimal time of incubation, in a previous experiment test molecules 
(DHC3µM, DHF 3µM, DHC3µM and DHF3µM ) at physiological concentrations were 
incubated for 1, 3 and 24 h in duplicate.  
 
3.2.3 Determination of superoxide anion production  
The cultures treated as described above were recovered by scraping the cell layer into a tube 
containing 5 ml of RPMI 1640 and centrifuged for 10 min at 1500rpm. The cellular 
precipitate was resuspended and homogenized in RPMI 1640 without red phenol (1x106 
cells/ml). The samples were incubated with lucigenin 10-4 M for 30 min at 37°C and 
subsequently stimulated with PMA (final concentration of 10-7 M) for chemiluminescence 
assay. Such stimulation of cells causes a gradual increase in O2°- production as shown in 
Figure 1. 
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Figure 1. Typical course of O2°- production in PMA and non PMA stimulated cells.  
 
 
The resulting O2°−-dependent luminescence was immediately recorded for 1h at 37°C using a 
Wallac Luminometer (Wallac Co., Turku, Finland) (Vachier et al. 1994, Delbosc et al. 2002). 
At the end of the experiment, the cellular medium was pooled for protein determination 
(Lowry et al. 1951).  
 
3.2.4 Expression of results 
The results of bioluminescence was expressed as luminescence unit/protein (LU/µg protein) 
in THP-1 cells. The 100% effect corresponded to the response of cells activated with PMA 
and incubated with only the solvent vehicle of polyphenol solution. The volume was 
standardized considering the conditions in which the solvent was employed at a maximum 
concentration for preparation and incubation of catabolites. Experiments were performed in 
triplicate comparing the percentage of O2°− production to control (100%).  
All data were expressed as means ±SD for three experiments. 
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3.3 Results 
 
3.3.1 Time course of inhibition 
As a first step the single molecules DHC, DHF, and their mixture were tested respectively at a 
concentration of 3µM and 6µM. The effect on O2°− inhibition in THP-1 cells was assessed 
after 1, 3 and 24h of incubation. A small inhibitory effect was observed at 3h for all the 
samples. At 24h, DHC and the mixture showed a minimum inhibition. After 1h of incubation 
inhibition was present only when the molecules were tested together. Results are reported in 
Figure 2.  
 
 
 
Figure 2. Time course of inhibition 
 
 
 
3.3.2 Superoxide anion production in THP-1 cells 
 
Considering the results of the inhibition kinetic, all the catabolites were incubated at 3 h and 
24h. The results (Mean±SD) are reported in Table 1. 
 
 
 
 
 
68 
Table 1. % O2°- production in THP1- cells1 
  24 H INCUBATION  3H INCUBATION  
  Mean SD Mean SD 
DHC 3µM 98,7 11,1 103,7 19,3 
DHF 3µM 101,9 4,8 96,31 3,8 
FG 3µM 104,1 16 94,6 4,1 
MIX 9µM 115,9 16,9 109,5 4 
PA 5µM 107,2 11,6 107,6 9 
33HPP 5µM 116,3 30,7 110,8 22,7 
HVA 5µM 94,3 10,6 102,7 9,6 
HPA 5µM 102,9 11,4 103 10,6 
MIX 20µM 104,4 21,1 106,2 18,3 
1values are reported as mean±SD, n=3. 
 
The O2°− production in monocytes after 3 h of incubation (Figure 3) with coffee and berry 
catabolites was above the control sample (100%) and a negligible inhibition was found for 
both DHF and FG.  
At 24 h of incubation (Figure 4) the inhibition percent was also above 100% (indicating 
activation), and only DHC, HVA showed an inhibitory effect, although too low to be 
considered of biological relevance. 
At physiological concentrations, the catabolites did not present inhibitory effect also when 
tested as a mixture. 
 
 
 
 
Figure 3. Coffee and berry catabolites at 3 h of incubation. 
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Figure 4. Coffee and berry catabolites at 24 h of incubation. 
 
 
 
 
3.4 Discussion 
In this study we found that the colonic catabolites of coffee and berries are not capable to 
protect the monocyte cells THP-1 against PMA-stimulated production of O2°- through 
modulation of NADPH system. The bioluminescence assay of catabolites tested at 
physiological concentration (3 and 5 µM) did not show a significant anion superoxide 
inhibition. Similar negative results were obtained at higher concentrations (9 and 20 µM) and 
when catabolites were tested as a mixture to evaluate the synergistic effect.  
Protection of monocytes against superoxide anion production was achieved in different 
studies when the molecules tested were native polyphenols from foods. In our study we 
demonstrate that the polyphenol catabolites, i.e. the molecules which are likely those that may 
reach the cell in the internal body compartments, are not able to exert a similar effect on 
NADPH oxidase modulation hopeful target for atherosclerosis prevention.  
NADPH oxidase is a complex system whose core is composed of five components and whose 
activation needs the phosphorylation of some components and the transfer of all the 
components to the plasma membrane. In the resting cell, the proteins p47phox, p67phox, 
p40phox, Rac 2 are present in the cytosol, while cytochrome b558 (the complex p22phox, 
gp91phox), and Rap1A are present on the membrane (Babior 1999). PKC is a protein able to 
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phosphorylate the p47 subunit (Chanock et al. 1994), and its inhibition leads to oxidase 
inactivation and O2°- decreased production. Pignatelli et al. (2006) found a synergistic effect 
of quercetin and catechin to inhibit PKC-dependent phosphorylation of the cytosolic sub – 
unit p47 phox of NADPH. 
Some of the mechanisms suggested by previous research for cellular modulation and O2°- 
production are the expression and phosphorylation of proteins for assembling the NADPH 
system and activation of protein kinase C (Leger et al. 2000, Cachia et al. 1998).  
Our study is the first to look at the effect of colonic catabolites at physiological concentrations 
on NADPH oxidase modulation in THP-1 cell line, assessed both individually and in mixture 
to investigate any possible synergistic effect. Our data suggest that a reduction of oxidative 
stress through inhibition of O2°- production was not achieved with molecules derived from 
berries and coffee when the experimental design takes into account the metabolic fate of 
dietary polyphenols. These results strongly suggest that the protective effect of polyphenols in 
vascular dysfunctions such as atherosclerosis, whose characteristic is an inflammatory state 
and excessive ROS production, is likely to be due to other mechanism of action which should 
be further investigated in order to highlight the potential role of antioxidant-rich foods and 
beverages to the risk of cardiovascular disease.  
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CHAPTER 4: OVERALL CONCLUSIONS 
Contrary to the hypothesis, the outcomes of the survey on dietary intake of betaine showed a 
positive correlation with some components of the metabolic syndrome and with the 
inflammatory biomarker C-reactive protein, an independent risk factor of cardiovascular 
events, whereas dietary choline showed no association.  
Moreover, the results obtained in our in vitro study demonstrated that polyphenol catabolites 
of colonic origin are not capable to reduce the oxidative stress through modulation of NADPH 
system. These data seem to indicate that the protection exerted by dietary sources of these 
classes of molecules, such as whole grain cereals, fruits and vegetables, is not directly related 
to the compounds assessed in this study, or at least, is not specifically related to the 
mechanisms investigated. Further studies are warranted in order to elucidate the role of 
betaine and choline, as well as the role of phenolics, in the beneficial effects of whole grain 
cereals, fruits and vegetables on risk of cardiovascular disease and atherosclerosis.  
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